<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2679667-A1" country="EP" doc-number="2679667" kind="A1" date="20140101" family-id="46721043" file-reference-id="307894" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146549825" ucid="EP-2679667-A1"><document-id><country>EP</country><doc-number>2679667</doc-number><kind>A1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12749891-A" is-representative="YES"><document-id mxw-id="PAPP154823748" load-source="docdb" format="epo"><country>EP</country><doc-number>12749891</doc-number><kind>A</kind><date>20120224</date><lang>JA</lang></document-id><document-id mxw-id="PAPP170521130" load-source="docdb" format="original"><country>EP</country><doc-number>12749891.3</doc-number><date>20120224</date><lang>JA</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140453523" ucid="JP-2011040651-A" load-source="docdb"><document-id format="epo"><country>JP</country><doc-number>2011040651</doc-number><kind>A</kind><date>20110225</date></document-id></priority-claim><priority-claim mxw-id="PPC140451087" ucid="JP-2012055294-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>JP</country><doc-number>2012055294</doc-number><kind>W</kind><date>20120224</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-2062986229" load-source="docdb">C07K  14/395       20060101ALI20150420BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2062988398" load-source="docdb">C12N   1/22        20060101ALI20150420BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2062988651" load-source="docdb">C12P   7/10        20060101ALI20150420BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2062993904" load-source="docdb">C12N   9/12        20060101ALI20150420BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2062994534" load-source="docdb">C12N   1/19        20060101AFI20150420BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1873986506" load-source="docdb" scheme="CPC">Y02E  50/17        20130101 LA20161128BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900024004" load-source="docdb" scheme="CPC">C12P   7/10        20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900025476" load-source="docdb" scheme="CPC">C07K  14/395       20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900025583" load-source="docdb" scheme="CPC">C12N  15/09        20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900027519" load-source="docdb" scheme="CPC">Y02P  20/52        20151101 LA20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900029332" load-source="docdb" scheme="CPC">Y02E  50/16        20130101 LA20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900031427" load-source="docdb" scheme="CPC">C12N   1/22        20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900031626" load-source="docdb" scheme="CPC">C12N   9/1205      20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1900032416" load-source="docdb" scheme="CPC">C12Y 207/01023     20130101 LI20160830BHEP        </classification-cpc><classification-cpc mxw-id="PCL2083076054" load-source="docdb" scheme="CPC">C12N  15/81        20130101 LI20140612BHEP        </classification-cpc><classification-cpc mxw-id="PCL2083076274" load-source="docdb" scheme="CPC">C12P   7/06        20130101 FI20140612BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132181959" lang="DE" load-source="patent-office">XYLOSE-FERMENTIERENDER MIKROORGANISMUS</invention-title><invention-title mxw-id="PT132181960" lang="EN" load-source="patent-office">XYLOSE-FERMENTING MICROORGANISM</invention-title><invention-title mxw-id="PT132181961" lang="FR" load-source="patent-office">MICROORGANISME DE FERMENTATION DU XYLOSE</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR918157458" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SUNTORY HOLDINGS LTD</last-name><address><country>JP</country></address></addressbook></applicant><applicant mxw-id="PPAR918141529" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SUNTORY HOLDINGS LIMITED</last-name></addressbook></applicant><applicant mxw-id="PPAR918989502" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Suntory Holdings Limited</last-name><iid>101120681</iid><address><street>1-40 Dojimahama 2-chome</street><city>Kita-ku Osaka-shi Osaka 530-8203</city><country>JP</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918139888" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>HATANAKA HARUYO</last-name><address><country>JP</country></address></addressbook></inventor><inventor mxw-id="PPAR918144021" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>HATANAKA,Haruyo</last-name></addressbook></inventor><inventor mxw-id="PPAR918987924" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>HATANAKA,Haruyo</last-name><address><street>c/o Suntory Research Center 1-1-1 Wakayamadai Shimamoto-cho</street><city>Mishima-gun Osaka 618-8503</city><country>JP</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR918978815" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Vossius &amp; Partner</last-name><iid>100751388</iid><address><street>Siebertstrasse 4</street><city>81675 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="JP-2012055294-W"><document-id><country>JP</country><doc-number>2012055294</doc-number><kind>W</kind><date>20120224</date><lang>JA</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012115277-A1"><document-id><country>WO</country><doc-number>2012115277</doc-number><kind>A1</kind><date>20120830</date><lang>JA</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS548885423" load-source="docdb">AL</country><country mxw-id="DS548902849" load-source="docdb">AT</country><country mxw-id="DS548885424" load-source="docdb">BE</country><country mxw-id="DS548848768" load-source="docdb">BG</country><country mxw-id="DS548897852" load-source="docdb">CH</country><country mxw-id="DS548807430" load-source="docdb">CY</country><country mxw-id="DS548902850" load-source="docdb">CZ</country><country mxw-id="DS548885425" load-source="docdb">DE</country><country mxw-id="DS548807431" load-source="docdb">DK</country><country mxw-id="DS548807432" load-source="docdb">EE</country><country mxw-id="DS548812549" load-source="docdb">ES</country><country mxw-id="DS548848769" load-source="docdb">FI</country><country mxw-id="DS548848770" load-source="docdb">FR</country><country mxw-id="DS548885426" load-source="docdb">GB</country><country mxw-id="DS548807433" load-source="docdb">GR</country><country mxw-id="DS548885427" load-source="docdb">HR</country><country mxw-id="DS548902851" load-source="docdb">HU</country><country mxw-id="DS548897853" load-source="docdb">IE</country><country mxw-id="DS548807434" load-source="docdb">IS</country><country mxw-id="DS548848771" load-source="docdb">IT</country><country mxw-id="DS548807435" load-source="docdb">LI</country><country mxw-id="DS548889971" load-source="docdb">LT</country><country mxw-id="DS548902852" load-source="docdb">LU</country><country mxw-id="DS548889972" load-source="docdb">LV</country><country mxw-id="DS548889973" load-source="docdb">MC</country><country mxw-id="DS548892380" load-source="docdb">MK</country><country mxw-id="DS548892381" load-source="docdb">MT</country><country mxw-id="DS548902853" load-source="docdb">NL</country><country mxw-id="DS548812550" load-source="docdb">NO</country><country mxw-id="DS548897858" load-source="docdb">PL</country><country mxw-id="DS548889974" load-source="docdb">PT</country><country mxw-id="DS548902854" load-source="docdb">RO</country><country mxw-id="DS548889975" load-source="docdb">RS</country><country mxw-id="DS548897859" load-source="docdb">SE</country><country mxw-id="DS548889976" load-source="docdb">SI</country><country mxw-id="DS548812551" load-source="docdb">SK</country><country mxw-id="DS548897860" load-source="docdb">SM</country><country mxw-id="DS548892390" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128670494" lang="EN" load-source="patent-office"><p id="pa01" num="0001">The object of the present invention is to provide a microorganism capable of maintaining its xylose fermentation ability over a long period of time.</p><p id="pa02" num="0002">The present invention provides a microorganism deficient in the function of expressing NAD kinase gene and/or <i>FPS1</i> gene, a method for preparing the above microorganism and a method for producing ethanol using the above microorganism.<img id="iaf01" file="imgaf001.tif" wi="74" he="124" img-content="drawing" img-format="tif"/></p></abstract><abstract mxw-id="PA128499867" lang="EN" source="EPO" load-source="docdb"><p>The object of the present invention is to provide a microorganism capable of maintaining its xylose fermentation ability over a long period of time.  The present invention provides a microorganism deficient in the function of expressing NAD kinase gene and/or  FPS1  gene, a method for preparing the above microorganism and a method for producing ethanol using the above microorganism.</p></abstract><description mxw-id="PDES63955924" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001">TECHNICAL FIELD</heading><p id="p0001" num="0001">The present invention relates to a microorganism deficient in the function of expressing NAD kinase gene. The present invention also relates to a method for preparing a fermentative microorganism whose xylose fermentation ability is increased by causing a deficiency in the function of NAD kinase gene. The present invention further relates to a method for producing ethanol, which comprises a step of contacting the above microorganism with xylose-containing raw materials.</p><heading id="h0002">BACKGROUND ART</heading><p id="p0002" num="0002">In recent years, in terms of fossil fuel depletion and/or the necessity of CO<sub>2</sub> gas reduction, studies have been pursued to produce ethanol as a fuel from biomass such as corncob, rice straw, switchgrass, Erianthus, scrap wood and so on, which have been wasted. Since many thousands of years ago, humans have already had techniques to convert starch into ethanol through fermentation by the action of yeast <i>Saccharomyces cerevisiae.</i> Starch is a polysaccharide composed of glucoses linked via α-1,4 linkages and can be easily degraded by the action of hydrolases present in various organisms. Glucose is the most preferred carbon source for yeast <i>Saccharomyces cerevisiae,</i> and two molecules of ethanol are produced through fermentation from one molecule of glucose. In contrast, biomass contains cellulose or hemicellulose as a polysaccharide.</p><p id="p0003" num="0003">Among them, cellulose is a polysaccharide composed of glucoses linked via β-1,4 linkages and is in a crystalline structure. Cellulose has some problems, e.g., in that pretreatment is required to disrupt its crystalline structure and in that enzymes required for its degradation, such as cellobiohydrolase I, cellobiohydrolase II and endoglucanase, do not have sufficient activity. However, there is no problem in fermenting cellulose by the action of yeast <i>Saccharomyces cerevisiae,</i> because the sugar produced after degradation is glucose.</p><p id="p0004" num="0004">In contrast, hemicellulose comprises not only glucose, but also pentoses such as xylose and arabinose. However, yeast <i>Saccharomyces cetevisiae</i> is conventionally unable to ferment these pentoses. For this reason, techniques to allow genes for xylose reductase and xylitol dehydrogenase from xylose-fermentable yeast <i>Pichia stipitis</i> to be highly expressed in yeast <i>Saccharomyces cerevisiae</i> have often been used for xylose fermentation (<figref idrefs="f0001">Figure 1</figref>). Xylose reductase in <i>Pichia stipitis</i> is an enzyme that uses NADPH as a major coenzyme, and one molecule of NADP is generated after reaction. On the other hand, xylitol dehydrogenase is an enzyme that uses NAD as a major<!-- EPO <DP n="2"> --> coenzyme, and one molecule of NADH is generated after reaction. Thus, as shown in <figref idrefs="f0001">Figure 1</figref>, the balance of NADP/NADPH or NAD/NADH remains unchanged during glucose fermentation, whereas this balance is shifted to increase NADP or NADH during xylose fermentation. This would be responsible for the low yield in ethanol fermentation from xylose.</p><p id="p0005" num="0005">Many attempts have been made to prepare a mutated xylose reductase whose coenzyme specificity is altered to NADH (Non-patent Document 1), to prepare a mutated xylitol dehydrogenase whose coenzyme specificity is altered to NADPH (Non-patent Document 2), to design an experiment where a gene for the glycolytic enzyme glyceraldehyde triphosphate dehydrogenase with coenzyme specificity for NADPH is introduced from another organism species (Non-patent Document 3), and to express transhydrogenases (which transfer hydrogen between NADPH and NAD or between NADP and NADH) derived from bacteria such as <i>E. coli</i> (Non-patent Document 4), but these attempts have not succeeded in providing sufficient effects.</p><heading id="h0003">Prior Art Documents</heading><heading id="h0004">Non-patent Documents</heading><p id="p0006" num="0006"><ul><li>Non-patent Document 1: <nplcit id="ncit0001" npl-type="s"><text>Petschacher B, Nidetzky B. Microb Cell Fact. 2008 Mar 17; 7: 9</text></nplcit>.</li><li>Non-patent Document 2: <nplcit id="ncit0002" npl-type="s"><text>Watanabe S, Saleh AA, Pack SP, Annaluru N, Kodaki T, Makino K. J Biotechnol. 2007 Jun 30; 130(3): 316-9. Epub 2007 Apr 29</text></nplcit>.</li><li>Non-patent Document 3: <nplcit id="ncit0003" npl-type="s"><text>Verho R, Londesborough J, Penttile M, Richard P. Appl Environ Microbiol. 2003 Oct; 69(10): 5892-7</text></nplcit>.</li><li>Non-patent Document 4: <nplcit id="ncit0004" npl-type="s"><text>Mikael Anderlund et.al. Appl Environ Microbiol. 1999 June 65(6): 2333-2340</text></nplcit></li></ul></p><heading id="h0005">DISCLOSURE OF THE INVENTION</heading><p id="p0007" num="0007">Under these circumstances, there is a demand for the development of a microorganism capable of maintaining its xylose fermentation ability over a long period of time.</p><p id="p0008" num="0008">Based on the concept that it is important to increase intracellular NAD or NADPH levels as a strategy for increasing the yield of ethanol in xylose fermentation, the inventors of the present invention have made extensive and intensive efforts with a focus on NAD(H) kinase. As a result, the inventors of the present invention have found that a decrease in NAD levels during the following reaction: <maths id="math0001" num=""><math display="block"><mi>NAD</mi><mo>+</mo><mi>ATP</mi><mo>→</mo><mi>NADP</mi><mo>+</mo><mi>ADP</mi></math><img id="ib0001" file="imgb0001.tif" wi="54" he="7" img-content="math" img-format="tif"/></maths><br/>
can be prevented when NAD(H) kinase gene is disrupted. Then, the inventors of the present invention have prepared a yeast strain whose NAD kinase gene is disrupted and<!-- EPO <DP n="3"> --> have performed xylose fermentation using this yeast strain. As a result, this strain was found to improve the yield of ethanol in comparison with the same strain of wild type.</p><p id="p0009" num="0009">The present invention is based on the above findings.</p><p id="p0010" num="0010">Namely, the present invention is directed to the following.
<ol><li>[1] A microorganism deficient in the function of expressing NAD kinase gene.</li><li>[2] The microorganism according to [1] above, wherein the NAD kinase gene is at least one selected from <i>UTR1</i> gene and <i>YEF1</i> gene.</li><li>[3] The microorganism according to [1] or [2] above, which is further deficient in the function of expressing <i>FPS1</i> gene.</li><li>[4] The microorganism according to any one of [1] to [3] above, which is yeast.</li><li>[5] The microorganism according to any one of [1] to [3] above, which is <i>Saccharomyces cerevisiae.</i></li><li>[6] The microorganism according to any one of [1] to [5] above, which is transformed with a xylose-metabolizing enzyme gene.</li><li>[7] The microorganism according to [6] above, wherein the xylose-metabolizing enzyme gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</li><li>[8] A method for preparing a microorganism whose xylose fermentation ability is increased by causing a deficiency in the function of expressing NAD kinase gene.</li><li>[9] The method according to [8] above, wherein the NAD kinase gene is at least one selected from <i>UTR1</i> gene and <i>YEF1</i> gene.</li><li>[10] The method according to [8] or [9] above, which further comprises a step of causing a deficiency in the function of expressing <i>FPS1</i> gene.</li><li>[11] The method according to any one of [8] to [10] above, wherein the microorganism is yeast.</li><li>[12] The method according to any one of [8] to [10] above, wherein the microorganism is <i>Saccharomyces cerevisiae.</i></li><li>[13] The method according to any one of [8] to [12] above, wherein the microorganism is transformed with a xylose-metabolizing enzyme gene.</li><li>[14] The method according to [13] above, wherein the xylose-metabolizing enzyme gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</li><li>[15] A method for producing ethanol, which comprises a step of contacting the microorganism according to any one of [1] to [7] above with xylose-containing raw materials.</li><li>[16] A microorganism deficient in the function of expressing <i>FPS1</i> gene.</li><li>[17] The microorganism according to [16] above, which is yeast.</li><li>[18] The microorganism according to [16] above, which is <i>Saccharomyces cerevisiae.</i></li><li>[19] The microorganism according to any one of [16] to [18] above, which is<!-- EPO <DP n="4"> --> transformed with a xylose-metabolizing enzyme gene.</li><li>[20] The microorganism according to [19] above, wherein the xylose-metabolizing enzyme gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</li><li>[21] A method for preparing a microorganism whose xylose fermentation ability is increased by causing a deficiency in the function of expressing <i>FPS1</i> gene.</li><li>[22] The method according to [21] above, wherein the microorganism is yeast.</li><li>[23] The method according to [21] above, wherein the microorganism is <i>Saccharomyces cerevisiae.</i></li><li>[24] The method according to any one of [21] to [23] above, wherein the microorganism is transformed with a xylose-metabolizing enzyme gene.</li><li>[25] The method according to [24] above, wherein the xylose-metabolizing enzyme gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</li><li>[26] A method for producing ethanol, which comprises a step of contacting the microorganism according to any one of [16] to [20] above with xylose-containing raw materials.</li></ol></p><p id="p0011" num="0011">The present invention provides a microorganism excellent in xylose fermentation ability. Moreover, the microorganism of the present invention shows high xylose fermentation ability, either on a small scale or on a large scale which involves stirring. The microorganism of the present invention can also maintain its xylose fermentation ability at high level even when used in long-term fermentation such as serial batch fermentation (serial fermentation in which cropped yeast is reused). Moreover, with the use of a method for preparing the microorganism of the present invention, bred lines with high xylose fermentation ability can also be prepared from a wide range of microorganisms which are used as hosts. The microorganism of the present invention allows efficient production of ethanol starting from xylose-containing raw materials. Moreover, the microorganism of the present invention also allows efficient production of ethanol, even starting from biomass with low amino acid content, as long as such biomass contains xylose.</p><heading id="h0006">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p0012" num="0012"><ul><li><figref idrefs="f0001">Figure 1</figref> shows the metabolic pathway of glucose and xylose.</li><li><figref idrefs="f0002">Figure 2</figref> shows a schematic view of plasmid pENTUTR1 used in the Example section.</li><li><figref idrefs="f0003">Figure 3</figref> shows a schematic view of plasmid pENTYEF1 used in the Example section.</li><li><figref idrefs="f0004">Figure 4</figref> shows a schematic view of plasmid pYRGFLP used in the Example section.<!-- EPO <DP n="5"> --></li><li><figref idrefs="f0005">Figure 5</figref> shows a schematic view of plasmid pYRNFLP used in the Example section.</li><li><figref idrefs="f0006">Figure 6</figref> shows a schematic view of plasmid pENTUTR1G used in the Example section.</li><li><figref idrefs="f0007">Figure 7</figref> shows a schematic view of plasmid pENTYEF1N used in the Example section.</li><li><figref idrefs="f0008">Figure 8</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH473). In the figure, "ΔXylose" denotes a decrement in xylose level, while "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0009">Figure 9</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH468). In the figure, Xylose" denotes a decrement in xylose level, while "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0010">Figure 10</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH473). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0011">Figure 11</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH473, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0012">Figure 12</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0013">Figure 13</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0014">Figure 14</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: CSLX, host: HH472). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0015">Figure 15</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: CSLX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0016">Figure 16</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: CSLX, host: HH472, 45 mL scale, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0017">Figure 17</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: CSLX, host: HH472, 45 mL scale, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0018">Figure 18</figref> shows the results of xylose fermentation test using the microorganism of the present invention (xylitol production level, medium: CSLX, host: HH472, 45 mL scale, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0019">Figure 19</figref> shows the results of xylose fermentation test using the<!-- EPO <DP n="6"> --> microorganism of the present invention (glycerol production level, medium: CSLX, host: HH472, 45 mL scale, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0020">Figure 20</figref> shows the results of serial batch xylose fermentation test using the microorganism of the present invention (medium: CSLX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0021">Figure 21</figref> shows the results of continuous xylose fermentation test using the microorganism of the present invention (xylose assimilation level, medium: CSLX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0022">Figure 22</figref> shows the results of continuous xylose fermentation test using the microorganism of the present invention (xylitol production level, medium: CSLX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0023">Figure 23</figref> shows the results of continuous xylose fermentation test using the microorganism of the present invention (glycerol production level, medium: CSLX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" denotes "<i>UTR1</i> gene disruption."</li><li><figref idrefs="f0024">Figure 24</figref> shows the results of xylose fermentation test (2) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0025">Figure 25</figref> shows the results of xylose fermentation test (2) using the microorganism of the present invention (medium: YPX, host: HH472, measured after 48 hours). In the figure, "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0026">Figure 26</figref> shows a schematic view of plasmid pCR4FPS1 used in the Example section.</li><li><figref idrefs="f0027">Figure 27</figref> shows a schematic view of plasmid pYR-AFLP used in the Example section.</li><li><figref idrefs="f0028">Figure 28</figref> shows a schematic view of plasmid pCR4FPS1AUR used in the Example section.</li><li><figref idrefs="f0029">Figure 29</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH472, measured after 48 hours). In the figure, "ΔXYL" denotes a decrement in xylose level, while "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0030">Figure 30</figref> shows the results of xylose fermentation test using the microorganism of the present invention (medium: YPX, host: HH472, measured after 48 hours). In the figure, "Δfps1," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.<!-- EPO <DP n="7"> --></li><li><figref idrefs="f0031">Figure 31</figref> shows the results of fermentation test using the microorganism of the present invention (medium: YPD, host: HH472, measured after 24 hours). In the figure, "ΔGLC" denotes a decrement in glucose level, while "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0032">Figure 32</figref> shows the results of fermentation test using the microorganism of the present invention (medium: YPD, host: HH472, measured after 24 hours). In the figure, "Δfps1," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0033">Figure 33</figref> shows the results of xylose fermentation test (50 ml scale) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "Δy<i>ef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0034">Figure 34</figref> shows the results of xylose fermentation test (50 ml scale) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δfps1," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0035">Figure 35</figref> shows the results of xylose fermentation test (50 ml scale) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0036">Figure 36</figref> shows the results of xylose fermentation test (50 ml scale) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "Δ<i>yef1</i>" denote "<i>FPS1</i> gene disruption," "<i>UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li><li><figref idrefs="f0037">Figure 37</figref> shows the results of xylose fermentation test (50 ml scale) using the microorganism of the present invention (medium: YPX, host: HH472). In the figure, "Δ<i>fps1</i>," "Δ<i>utr1</i>" and "A<i>yef1</i>" denote "<i>FPS1</i> gene disruption," <i>"UTR1</i> gene disruption" and "<i>YEF1</i> gene disruption," respectively.</li></ul></p><heading id="h0007">BEST MODES FOR CARRYING OUT THE INVENTION</heading><p id="p0013" num="0013">The present invention will be described in more detail below. The following embodiments are illustrated to describe the present invention, and it is not intended to limit the present invention only to these embodiments. The present invention can be implemented in various modes, without departing from the spirit of the present invention.</p><p id="p0014" num="0014">It should be noted that all publications cited herein, including prior art documents, patent gazettes and other patent documents, are incorporated herein by reference. Moreover, this specification incorporates the contents disclosed in the specification and drawings of Japanese Patent Application No. <patcit id="pcit0001" dnum="JP2011040651A"><text>2011-040651 (filed on<!-- EPO <DP n="8"> --> February 25, 2011</text></patcit>), based on which the present application claims priority.</p><p id="p0015" num="0015">The inventors of the present invention have found that when using a microorganism strain modified to suppress NAD kinase gene expression, the efficiency of ethanol production from xylose-containing raw materials is improved in comparison with a wild-type strain of the same species, and thus have completed the present invention. The inventors of the present invention have further found that when suppressing the expressions of glycerol channel genes, the efficiency of ethanol production from xylose-containing raw materials is further improved. The respective embodiments of the present invention will be described below.</p><heading id="h0008">1. Microorganism deficient in the function of NAD kinase gene</heading><p id="p0016" num="0016">In a certain embodiment, the present invention provides a microorganism deficient in the function of expressing NAD kinase gene.</p><p id="p0017" num="0017">In the context of the present invention, the term "microorganism" is intended to mean an organism whose existence cannot be found by the unaided eye and whose size is equal to or smaller than that detectable under a microscope, etc. Examples of such a microorganism include prokaryotic organisms such as bacteria, cyanobacteria and archaebacteria, as well as eukaryotic organisms such as filamentous fungi, yeast, myxomycetes, basidiomycetes, unicellular algae and protozoa.</p><p id="p0018" num="0018">A preferred microorganism is of species with sugar fermentation ability, and more preferred is yeast, which may be either budding yeast or fission yeast. In a certain embodiment, the yeast may be budding yeast such as <i>Saccharomyces cerevisiae</i> NBRC1951, NBRC1952, NBRC1953, NBRC1954, X2180-1A (ATCC26786), CB11 (Berkley Stock Center), W303-1A (BY4848), etc. In another embodiment, the yeast may be fission yeast such as <i>Schizosaccharomyces japonicus</i> (<i>Hasegawaea japonicus</i>), <i>Schizosaccharomyces octosporus</i> (<i>Octosporomyces octosporus</i>), <i>Schizosaccharomyces pombe</i>, etc.</p><p id="p0019" num="0019">In the context of the present invention, the term "NAD kinase gene" is intended to mean a gene encoding NAD kinase protein, which may be either DNA or RNA. NAD kinase is an enzyme having the activity to convert nicotinamide adenine dinucleotide (NAD) into nicotinamide adenine dinucleotide phosphate (NADP) through phosphate addition (hereinafter referred to as "NAD kinase activity") (<nplcit id="ncit0005" npl-type="s"><text>Magni G et al., (2006) Mini reviews in medicinal chemistry 6 (7): 739-46</text></nplcit>).</p><p id="p0020" num="0020">As used herein, the term "NAD kinase gene" is not limited to a gene (SEQ ID NO: 1 or 3) encoding a <i>Saccharomyces cerevisiae</i>-derived NAD kinase protein (SEQ ID NO: 2 or 4), and may also be a gene encoding a homolog protein which has NAD kinase activity and belongs to the same family as NAD kinase. Such proteins belonging to the same family as NAD kinase have been found in many plants and are<!-- EPO <DP n="9"> --> highly conserved throughout the family. Since NAD kinase is an enzyme important for cell metabolism, a gene for this enzyme is highly conserved throughout the family. The genes for NAD kinases or homolog proteins thereof have already been analyzed for their nucleotide sequences in a plurality of microorganisms, and the sequence information thereof have been registered in the database (see Table 1).
<tables id="tabl0001" num="0001"><table frame="all"><title><u>Table 1</u></title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="47mm"/><colspec colnum="2" colname="col2" colwidth="29mm"/><colspec colnum="3" colname="col3" colwidth="91mm"/><thead><row><entry align="center" valign="middle"><b>Species</b></entry><entry align="center" valign="middle"><b>Gene name</b></entry><entry align="center" valign="middle"><b>GenBank Accession No. of CDS / the CDS position in chromosome or whole genome sequence</b></entry></row></thead><tbody><row><entry morerows="1" align="center" valign="middle"><i>Saccharomyces cerevisiae</i></entry><entry><i>UTR1</i></entry><entry valign="middle">NM_001181707 (Saccharomyces Genome Database Accession No YJR049C) SEQ ID NO: 1</entry></row><row><entry><i>YEF1</i></entry><entry valign="middle">NM_001178856: SEQ ID NO: 3</entry></row><row><entry align="center" valign="middle"><i>Schizosaccharomyces pombe</i></entry><entry>SPCC24B10.02c</entry><entry valign="middle">NM_001022996</entry></row><row><entry align="center" valign="middle"><i>Pichia stipitis</i></entry><entry>NAD kinase</entry><entry valign="middle">XM_001383120</entry></row><row><entry align="center" valign="middle"><i>Aspergillus oryzae</i></entry><entry>NAD kinase</entry><entry valign="middle">XM_001824067</entry></row><row><entry align="center" valign="middle"><i>Aspergillus niger</i></entry><entry>NAD kinase</entry><entry valign="middle">XM_001401229</entry></row><row><entry align="center" valign="middle"><i>Pichia angusta</i></entry><entry>NAD kinase</entry><entry valign="middle">Position 1304477-1306453 of whole genome sequence: AEOI_01000012</entry></row></tbody></tgroup></table></tables></p><p id="p0021" num="0021">In the case of using <i>Saccharomyces cerevisiae</i> to prepare the microorganism of the present invention, the NAD kinase gene is preferably <i>UTR1</i> gene (SEQ ID NO. 1) or <i>YEF1</i> gene (SEQ ID NO: 3).</p><p id="p0022" num="0022">In one embodiment, the NAD kinase gene may be a mutant with deletion, insertion, substitution or addition of one or more nucleotides in the nucleotide sequence of a polynucleotide encoding a polypeptide with NAD kinase activity Such a mutant may be mutated in either or both of coding and non-coding regions Mutations in coding regions may produce conservative or non-conservative ammo acid deletions, insertions, substitutions and/or additions As used herein, the term "NAD kinase gene" also encompasses a gene encoding the amino acid sequence shown in SEQ ID NO 2 or SEQ ID NO. 4 or a gene encoding an ammo acid sequence with deletion, substitution or addition of one or more ammo acids (e.g., 1 to 40 amino acids, 1 to 20 amino acids, 1 to 15 amino acids, 1 to 10 ammo acids, 1 to 9 ammo acids, 1 to 8 ammo acids, 1 to 7 ammo acids, 1 to 6 amino acids, 1 to 5 ammo acids, 1 to 4 amino acids, 1 to 3 amino acids, 1 to 2 amino acids, a single amino acid, etc.) or one or few amino acids in the above ammo acid sequence<!-- EPO <DP n="10"> --></p><p id="p0023" num="0023">In the context of the present invention, the expression "deficient in the function of expressing NAD kinase gene" is intended to mean that NAD kinase having inherent enzymatic functions is not expressed from the NAD kinase gene. Examples of such a state include not only those where no expression product is produced from the NAD kinase gene, but also those where an expression product (e.g., hnRNA, mRNA or protein) of this gene is expressed but loses its inherent normal functions. Such a functional deficiency in the NAD kinase gene may be caused by deletion, substitution and/or insertion of one or more nucleotides in the NAD kinase gene or its expression control region comprising a transcriptional regulatory region or a promoter region. It should be noted that there is no particular limitation on the site where the above deletion, substitution and/or insertion occurs or on the sequence to be deleted, substituted and/or inserted, as long as the normal functions of the NAD kinase gene can be lost. In a preferred embodiment, at least one of the gene sequences encoding the enzymatically active sites of NAD kinase is deleted.</p><p id="p0024" num="0024">Particularly in the case of being a eukaryotic organism, the microorganism of the present invention may have an effect in cases where the function of expressing the above NAD kinase is lost in at least one allele on the chromosome (heterozygote), but is preferably lost in both alleles (homozygote).</p><p id="p0025" num="0025">Moreover, the microorganism of the present invention may be deficient in the function of <i>FPS1</i> gene, either alone or in addition to NAD kinase gene.<br/>
As used herein, the term "<i>FPS1</i> gene" is not limited to a gene (Saccharomyces Genome Database Accession No: YLL043W, Genbank Accession No: NM_001181863.1, SEQ ID NO: 23) encoding a <i>Saccharomyces cerevisiae-</i>derived <i>FPS1</i> protein (SEQ ID NO: 24), and may also be a gene encoding a protein which functions as a glycerol channel.</p><p id="p0026" num="0026">In one embodiment, the term "<i>FPS1</i> gene" also encompasses a gene encoding the amino acid sequence shown in SEQ ID NO: 24 or a gene encoding an amino acid sequence with deletion, substitution or addition of one or more amino acids (e.g., 1 to 40 amino acids, 1 to 20 amino acids, 1 to 15 amino acids, 1 to 10 amino acids, 1 to 9 amino acids, 1 to 8 amino acids, 1 to 7 amino acids, 1 to 6 amino acids, 1 to 5 amino acids, 1 to 4 amino acids, 1 to 3 amino acids, 1 to 2 amino acids, a single amino acid, etc.) or one or few amino acids in the above amino acid sequence.</p><p id="p0027" num="0027">In the context of the present invention, the expression "deficient in the function of expressing <i>FPS1</i> gene" is intended to mean that any <i>FPS1</i> protein having inherent enzymatic functions is not expressed from the <i>FPS1</i> gene. Examples of such a state include not only those where no expression product is produced from the <i>FPS1</i> gene, but also those where an expression product (e.g., hnRNA, mRNA or protein) of this<!-- EPO <DP n="11"> --> gene is expressed but loses its inherent functions as a glycerol channel. Such a functional deficiency in the <i>FPS1</i> gene can be caused by deletion, substitution and/or insertion of one or more nucleotides in the <i>FPS1</i> gene or its expression control region comprising a transcriptional regulatory region or a promoter region. It should be noted that there is no particular limitation on the site where the above deletion, substitution and/or insertion occurs or on the sequence to be deleted, substituted and/or inserted, as long as the functions of the <i>FPS1</i> gene as a glycerol channel can be lost. In a preferred embodiment, at least one of the gene sequences encoding the active sites of the <i>FPS1</i> protein is deleted.</p><p id="p0028" num="0028">Particularly in the case of being a eukaryotic organism, the microorganism of the present invention may have an effect in cases where the function of expressing the above <i>FPS1</i> is lost in at least one allele on the chromosome (heterozygote), but is preferably lost in both alleles (homozygote).</p><heading id="h0009">2. Method for preparing a fermentative microorganism whose xylose fermentation ability is increased</heading><p id="p0029" num="0029">The present invention provides a method for preparing a fermentative microorganism whose xylose fermentation ability is increased by causing a deficiency in the function of expressing NAD kinase gene in a host microorganism.<br/>
Moreover, the above method may further comprise a step of causing a deficiency in the function of expressing <i>FPS1</i> gene. Alternatively, without causing a deficiency in the function of expressing NAD kinase gene in a host microorganism, a fermentative microorganism whose xylose fermentation ability is increased can also be prepared by causing a deficiency only in the function of expressing <i>FPS1</i> gene.<br/>
Techniques used to cause a deficiency in the function of expressing NAD kinase gene or <i>FPS1</i> gene include knockout or knockdown techniques such as gene targeting or RNAi, etc.</p><heading id="h0010">(1) Gene targeting</heading><p id="p0030" num="0030">Gene targeting is a procedure for introducing a mutation into a specific gene on the chromosome by means of homologous recombination (<nplcit id="ncit0006" npl-type="s"><text>Capecechi, M.R. Science, 244, 1288-1292, 1989</text></nplcit>).</p><p id="p0031" num="0031">First, a targeting vector is constructed for use in causing a deficiency in the function of NAD kinase gene or <i>FPS1</i> gene. For targeting vector construction, a genomic DNA library of a target microorganism is prepared. To ensure that the frequency of recombination is not reduced by polymorphism, etc., this genomic DNA library is preferably prepared from genomic DNAs derived from a microorganism of the same group as the target microorganism of gene targeting, preferably a microorganism of the same species. Such a library may be a commercially available one.<!-- EPO <DP n="12"> --> Alternatively, the cDNA of NAD kinase or <i>FPS1</i> or a partial sequence thereof may be used as a probe in screening to clone the DNA sequence of the genomic gene of NAD kinase or <i>FPS1</i>, or primers may be prepared based on the cDNA of NAD kinase or <i>FPS1</i> or a partial sequence thereof to amplify the genomic NAD kinase gene or <i>FPS1</i> gene by PCR. For details of how to prepare a genomic DNA library, reference may be made to the following: "<nplcit id="ncit0007" npl-type="b"><text>Sambrook &amp; Russell, Molecular Cloning: A Laboratory Manual Vol. 3, Cold Spring Harbor Laboratory Press 2001</text></nplcit>," "<nplcit id="ncit0008" npl-type="b"><text>Ausubel, Current Protocols in Molecular Biology, John Wiley &amp; Sons 1987-1997</text></nplcit>."</p><p id="p0032" num="0032">Next, the cloned genomic DNA is analyzed by sequencing, Southern blotting, restriction enzyme digestion or the like to identify the positions of exons (in the case of eukaryotic organisms) and restriction enzyme sites. Based on the sequence information thus analyzed, mutation-bearing sites and so on are determined.</p><p id="p0033" num="0033">In the present invention, mutations (deletion, substitution and/or insertion) to be introduced onto the chromosome are not limited in any way as long as the normal functions of NAD kinase gene or <i>FPS1</i> gene are impaired, and these mutations may be located either in intron and/or exon regions of the NAD kinase gene or the <i>FPS1</i> gene or in expression control regions of the NAD kinase gene or the <i>FPS1</i> gene. The above mutations are preferably located in exon regions of the NAD kinase gene or the <i>FPS1</i> gene, more preferably located to cause deletion of at least one exon in the NAD kinase gene or the <i>FPS1</i> gene, and most preferably located to cause deletion of all exons. This is because such a mutation ensures functional impairment of the NAD kinase gene or the <i>FPS1</i> gene.</p><p id="p0034" num="0034">The targeting vector may comprise not only homologous regions at the 3'- and 5'-sides of a mutation-bearing site (hereinafter referred to as 3'-arm and 5'-arm, respectively), but also a selection marker for use in recombinant selection. Examples of a selection marker include positive selection markers (e.g., neomycin resistance gene, hygromycin B phosphotransferase gene, kanamycin resistance gene), expression reporters for genes to be disrupted (e.g., <i>LacZ,</i> GFP (green fluorescence protein) and luciferase genes), negative selection markers (e.g., herpes simplex virus thymidine kinase gene (HSV-TK), diphtheria toxin A fragment (DTA)), etc. In particular, since the present invention uses a microorganism as a host, a gene for auxotrophic complementation, e.g., URA3 allows selection on a uracil-free agar medium, may also be used depending on the auxotrophy of the host. Likewise, the use of a drug resistance gene against cycloheximide (<i>YAP1</i>) allows selection on a cycloheximide-containing medium. Moreover, a sequence having such a selection marker inserted between 3'-arm and 5'-arm can be used to disrupt a target gene. The vector may comprise, at a position outside of each homologous region, an appropriate restriction enzyme cleavage site for linearization of the vector.<!-- EPO <DP n="13"> --></p><p id="p0035" num="0035"><figref idrefs="f0006">Figure 6</figref> shows an example of the targeting vectors used in the Example section for knockout of <i>Saccharomyces cerevisiae UTR1</i> gene. This construct is configured to comprise <i>UTR1</i> genomic gene sequences encoding the N-terminal and C-terminal amino acid sequences of <i>UTR1</i> protein as 5'-arm ("<i>UTR1</i>-N") and 3'-arm ("<i>UTR1</i>-C"), respectively, and geneticin resistance gene ("G418R") inserted as a positive selection marker between the 5'-arm and the 3'-arm.<br/>
This <i>UTR1-N-G418R-UTR1-</i>C fragment is excised from the vector with restriction enzymes, purified and then transformed into yeast cells to obtain a strain acquiring geneticin resistance by homologous recombination, followed by PCR to confirm <i>UTR1</i> gene disruption.<br/>
Such a targeting vector can be constructed starting from a commercially available plasmid vector (e.g., pENTR/D-TOPO<sup>®</sup> (Invitrogen) or pBluescriptII (Stratagene)).</p><heading id="h0011">(2) RNA interference</heading><p id="p0036" num="0036">Other techniques to cause a deficiency in the function of expressing NAD kinase gene or <i>FPS1</i> gene include RNA interference (RNAi) with siRNAs (small interfering RNAs), etc. RNAi is a multi-step process proceeding through a number of stages. First of all, double-stranded RNA (dsRNA) or hairpin-shaped shRNA (small hairpin RNA) expressed from an RNAi expression vector is recognized by Dicer and cleaved into siRNAs of 21 to 23 nucleotides. These siRNAs are then integrated into an RNAi targeting complex, which is called the RNA-induced silencing complex (RISC), and the complexes between RISC and siRNAs bind to target mRNA containing sequences complementary to the siRNA sequences and thereby cleave the mRNA. The target mRNA is cleaved in the center of its region complementary to the siRNA, finally leading to rapid degradation of the target mRNA and reduced protein expression levels. The most potent siRNA duplexes are known to be sequences of 21 nucleotides in length, each comprising a 19 bp duplex with an overhang of two uridine residues at the 3'-terminal end (<nplcit id="ncit0009" npl-type="s"><text>Elbashir S.M. et al., Genes and Dev, 15, 188-200 (2001</text></nplcit>)).</p><p id="p0037" num="0037">Thus, to obtain a microorganism knocked down for NAD kinase gene or <i>FPS1</i> gene, nucleotides covering a sequence complementary to a part of the NAD kinase gene as shown in Table 1 or a <i>FPS1</i> gene sequence (e.g., but not limited to, SEQ ID NO: 23) are first inserted as dsRNA or shRNA in an expressible state into an appropriate RNAi expression vector to thereby prepare an RNAi vector. The above vector may then be introduced into host cells, followed by selection of transformants to thereby obtain a microorganism knocked down for NAD kinase gene or <i>FPS1</i> gene.<br/>
Design and synthesis of dsRNA or shRNA may be accomplished by using a commercially available DNA/RNA synthesizer (e.g., Applied Biosystems model 394) or may be entrusted to a third party (e.g., TAKARA Bio).<!-- EPO <DP n="14"> --></p><p id="p0038" num="0038">A deficiency in the function of expressing NAD kinase gene or <i>FPS1</i> gene can be confirmed as a reduction in the expression level of normal NAD kinase gene or normal <i>FPS1</i> gene. The expression level of NAD kinase gene or <i>FPS1</i> gene can be measured using an extract of the microorganism of the present invention by RT-PCR and agarose gel electrophoresis, Real-Time PCR, Northern blotting, microarray analysis, as well as mass spectrometry, etc. Primers or probes for use in these measurements may be designed and synthesized on the basis of the sequence of the NAD kinase gene or the <i>FPS1</i> gene. Confirmation of whether an expression product of NAD gene is normal can be accomplished by sequence analysis of the expression product. The microorganism of the present invention, which is characterized by being deficient in the function of expressing NAD kinase gene or <i>FPS1</i> gene, may further have a xylose-metabolizing enzyme gene introduced in an expressible state. The term "xylose-metabolizing enzyme gene" is intended to mean a gene encoding a protein having the activity to catalyze any reaction among a series of chemical reactions for degrading xylose into ethanol (hereinafter referred to as "xylose-metabolizing activity") (such a protein is hereinafter referred to as a "xylose-metabolizing enzyme"). Examples of such a xylose-metabolizing enzyme gene include xylose reductase gene, xylitol dehydrogenase gene, and xylulose kinase gene.<br/>
<br/>
Such a xylose-metabolizing enzyme gene may be, for example, derived from <i>Pichia stipitis, Saccharomyces cerevisiae, E. coli, Lactobacillus casei, Lactobacillus acidophilus, Aspergillus fumigatus, Staphylococcus aureus, Pichia pastoris, Schizosaccharomyces pombe,</i> etc.<br/>
The microorganism of the present invention is preferably transformed with at least one xylose-metabolizing enzyme gene selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene or xylulose kinase gene, and may be transformed with two or more of these genes or with all of the three genes.<br/>
Examples of xylose reductase gene, xylitol dehydrogenase gene or xylulose kinase gene include, but are not limited to, those listed below.
<tables id="tabl0002" num="0002"><table frame="all"><title><u>Table 2</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="45mm"/><colspec colnum="2" colname="col2" colwidth="32mm"/><colspec colnum="3" colname="col3" colwidth="45mm"/><colspec colnum="4" colname="col4" colwidth="45mm"/><thead><row><entry namest="col1" nameend="col4" align="left" valign="top"><b>Xylose reductase genes</b></entry></row><row><entry align="center" valign="middle"><b>Microorganism species</b></entry><entry align="center" valign="middle"><b>Gene name</b></entry><entry valign="middle"><b>Genbank Accession No. (chromosome or whole genome sequence)</b></entry><entry valign="middle"><b>GenBank Accession No. of CDS / the CDS position in chromosome or whole genome sequence</b></entry></row></thead><tbody><row><entry><i>S. cerevisiae</i></entry><entry><i>GRE3</i> (YHR104W)</entry><entry align="center">NC_001140</entry><entry>NM_001179234.1</entry></row><row><entry><i>Lactobacillus acidophilus</i></entry><entry><i>LBA1037</i></entry><entry align="center">NC_006814</entry><entry>Position 1026933-1027815 of NC_006814</entry></row><!-- EPO <DP n="15"> --><row><entry><i>Pichia pastoris</i></entry><entry><i>PAS chr3 0744</i></entry><entry align="center">NC_012965</entry><entry>XM_0024929281</entry></row><row><entry><i>Pichia stipitis</i></entry><entry><i>XYL1</i></entry><entry align="center">NC_009045</entry><entry>X59465</entry></row><row><entry><i>Schizosaccharomyces pombe</i></entry><entry><i>yak3</i></entry><entry align="center">NC_003424</entry><entry>XM_0010199271</entry></row><row><entry><i>Aspergillus fumigatus</i></entry><entry><i>AFUA_1G04820</i></entry><entry align="center">NC_007194</entry><entry>XM_745138.1</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0003" num="0003"><table frame="all"><title><u>Table 3</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="40mm"/><colspec colnum="2" colname="col2" colwidth="32mm"/><colspec colnum="3" colname="col3" colwidth="47mm"/><colspec colnum="4" colname="col4" colwidth="48mm"/><thead><row><entry namest="col1" nameend="col4" align="left" valign="top"><b>Xylitol dehydrogenase genes</b></entry></row><row><entry align="center" valign="middle"><b>Microorganism species</b></entry><entry align="center" valign="middle"><b>Gene name</b></entry><entry valign="middle"><b>GenBank Accession No. (chromosome or whole genome sequence)</b></entry><entry valign="middle"><b>GenBank Accession No. of CDS / the CDS position in chromosome or whole genome sequence</b></entry></row></thead><tbody><row><entry><i>S. cerevisiae</i></entry><entry>XYL2 (YLR070C)</entry><entry>NC_001144</entry><entry>NM_001181957.1</entry></row><row><entry><i>S. cerevisiae</i></entry><entry>SOR1 (YJR159W)</entry><entry>NC_001142</entry><entry>NM_001181817.1</entry></row><row><entry><i>Aspergillus fumigatus</i></entry><entry>AFUA_1G16270</entry><entry>NC_007194</entry><entry>XM_7479001</entry></row><row><entry><i>Staphylococcus aureus</i></entry><entry>SAB0195</entry><entry>NC_007622</entry><entry>Position 243313-244338 of NC_007622</entry></row><row><entry><i>Pichia stipitis</i></entry><entry>XYL2</entry><entry>NC_009068 (SEQ ID NO: 11)</entry><entry>X55392</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0004" num="0004"><table frame="all"><title><u>Table 4</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="40mm"/><colspec colnum="2" colname="col2" colwidth="30mm"/><colspec colnum="3" colname="col3" colwidth="49mm"/><colspec colnum="4" colname="col4" colwidth="48mm"/><thead><row><entry namest="col1" nameend="col4" align="left" valign="top"><b>Xylulose kinase genes</b></entry></row><row><entry align="center" valign="middle"><b>Microorganism species</b></entry><entry align="center" valign="middle"><b>Gene name</b></entry><entry valign="middle"><b>GenBank Accession No (chromosome or whole genome sequence)</b></entry><entry valign="middle"><b>Genbank Accession No of CDS / the CDS position in chromosome or whole genome sequence</b></entry></row></thead><tbody><row><entry><i>S. cerevisiae</i></entry><entry>XKS1(YGR194C)</entry><entry>NC_001139</entry><entry>Position 886078-887880 of NC_001139</entry></row><row><entry><i>E. coli</i></entry><entry>ECBD0170</entry><entry>NC_012947</entry><entry>Position 181347-182801 of NC_012947</entry></row><row><entry><i>Pichia stipitis</i></entry><entry>XKS1</entry><entry>(SEQ ID NO 13)</entry><entry>XM_001387288.1</entry></row><row><entry><i>Staphylococcus aureus</i></entry><entry>xylB</entry><entry>NC_010999</entry><entry>Position 397478-398944 of NC_010999</entry></row></tbody></tgroup></table></tables></p><p id="p0039" num="0039">Xylose reductase is an enzyme catalyzing the following reaction during xylose degradation <maths id="math0002" num=""><math display="block"><mi>Xylose</mi><mo>+</mo><mi>NADPH</mi><mo>→</mo><mi>Xylitol</mi><mo>+</mo><mi>NADP</mi></math><img id="ib0002" file="imgb0002.tif" wi="68" he="7" img-content="math" img-format="tif"/></maths><!-- EPO <DP n="16"> --></p><p id="p0040" num="0040">Xylitol dehydrogenase is an enzyme catalyzing the following reaction during xylose degradation. <maths id="math0003" num=""><math display="block"><mi>Xylitol</mi><mo>+</mo><mi>NAD</mi><mo>→</mo><mi>Xylulose</mi><mo>+</mo><mi>NADH</mi></math><img id="ib0003" file="imgb0003.tif" wi="67" he="7" img-content="math" img-format="tif"/></maths></p><p id="p0041" num="0041">Xylulose kinase is an enzyme catalyzing the following reaction during xylose degradation. <maths id="math0004" num=""><math display="block"><mi>Xylulose</mi><mo>+</mo><mi>ATP</mi><mo>→</mo><mi>Xylulose</mi><mo>-</mo><mn mathvariant="normal">5</mn><mo>⁢</mo><mi mathvariant="normal">P</mi><mo>+</mo><mi>ADP</mi></math><img id="ib0004" file="imgb0004.tif" wi="70" he="7" img-content="math" img-format="tif"/></maths></p><p id="p0042" num="0042">In one embodiment, the xylose-metabolizing enzyme gene (e.g., xylose reductase, xylitol dehydrogenase or xylulose kinase) may be a mutant thereof as long as it encodes a protein having xylose-metabolizing activity. Examples of such a mutant include those having deletion, insertion, substitution or addition of one or more nucleotides in the nucleotide sequence of a polynucleotide encoding the above xylose-metabolizing enzyme protein. These mutants may be mutated in either or both of coding and non-coding regions. Mutations in coding regions may produce conservative or non-conservative amino acid deletions, insertions, substitutions and/or additions. As used herein, the term "xylose-metabolizing enzyme gene" also encompasses a gene (e.g., SEQ ID NO: 9, 11 or 13) encoding the amino acid sequence shown in SEQ ID NO: 10, 12 or 14 or a gene encoding an amino acid sequence with deletion, substitution or addition of one or more amino acids (e.g., 1 to 40 amino acids, 1 to 20 amino acids, 1 to 15 amino acids, 1 to 10 amino acids, 1 to 9 amino acids, 1 to 8 amino acids, 1 to 7 amino acids, 1 to 6 amino acids, 1 to 5 amino acids, 1 to 4 amino acids, 1 to 3 amino acids, 1 to 2 amino acids, a single amino acid, etc.) or one or few amino acids in the above amino acid sequence.</p><p id="p0043" num="0043">It is well known in the art that some amino acids in the amino acid sequence of a polypeptide can be easily modified without significantly affecting the structure or function of this polypeptide. In addition to artificial modifications, it is also well known that there are naturally occurring mutants of a protein, which do not significantly alter the structure or function of the protein.</p><p id="p0044" num="0044">Those skilled in the art would be able to easily modify one or more amino acids in the amino acid sequence of a polypeptide by using well-known techniques. For example, in accordance with known procedures for point mutagenesis, any nucleotide in a polynucleotide encoding a polypeptide can be modified. Moreover, primers corresponding to any site in a polynucleotide encoding a polypeptide may be designed and used to prepare a deletion mutant or an addition mutant. Further, when using the procedures described herein, it is possible to<!-- EPO <DP n="17"> --> easily determine whether or not the prepared mutant enzymes have desired activity.</p><p id="p0045" num="0045">Preferred mutant enzymes have conservative or non-conservative amino acid substitutions, deletions or additions, preferably silent substitutions, additions and deletions, and particularly preferably conservative substitutions. These modifications do not alter the polypeptide activity intended in the present invention.</p><p id="p0046" num="0046">Typical examples of conservative substitutions are replacement of one amino acid with another amino acid, each being selected from aliphatic amino acids Ala, Val, Leu and Ile, interchange between hydroxyl residues Ser and Thr, interchange between acidic residues Asp and Glu, replacement between amide residues Asn and Gln, interchange between basic residues Lys and Arg, as well as replacement between aromatic residues Phe and Tyr.</p><p id="p0047" num="0047">As described in detail above, further guidance as to which amino acid change is likely to be phenotypically silent (i.e., likely to have no significantly adverse effect on functions) can be found in <nplcit id="ncit0010" npl-type="s"><text>Bowie, J.U. et al., "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions," Science 247:1306-1310(1990</text></nplcit>), which is incorporated herein by reference.</p><p id="p0048" num="0048">With the use of the above polynucleotides according to the present invention, polypeptides having xylose-metabolizing enzyme activity can be synthesized in transformants or cells.</p><p id="p0049" num="0049">The xylose-metabolizing enzyme gene is preferably introduced in a state of being integrated into an expression vector expressible in host cells. Such an expression vector may comprise the following elements (i) to (iii):
<ol><li>(i) a promoter transcribable in host cells;</li><li>(ii) the xylose-metabolizing enzyme gene ligated to the promoter; and</li><li>(iii) an expression cassette comprising, as constituent elements, signals that function in the host cells for transcription termination and polyadenylation of an RNA molecule.</li></ol></p><p id="p0050" num="0050">Examples of such a vector include pYE22m (for yeast: <nplcit id="ncit0011" npl-type="s"><text>Biosci. Biotech. Biochem., 59, 1221-1228, 1995</text></nplcit>), YCp50 (for yeast: X70276), YIp1 (for yeast: X70480), etc.</p><p id="p0051" num="0051">Any combination of promoter/terminator may be used for regulating gene expression in host cells, as long as it functions in the host cells. For example, promoters available for use in yeast include, but are not limited to, <i>TDH3</i>p<i>, PYK1</i>p<i>, PGK1</i>p<i>, TPI1</i>p<i>, GAL1</i>p<i>, GAL10</i>p<i>, ADH2</i>p<i>, PHO5</i>p<i>, CUP1</i>p<i>, MF(ALPHA)1</i>p<i>,</i> etc. As a<!-- EPO <DP n="18"> --> promoter for constitutively high expression, it is possible to use a promoter such as <i>TDH3p, TPI1p, PGK1p, PGI1p, PYK1p, ADH1p,</i> etc.<br/>
Selection markers available for use in transformation include auxotrophic markers <i>(URA3, LEU2),</i> drug resistance markers (hygromycin resistance, geneticin resistance), copper resistance gene (<i>CUP1</i>) (<nplcit id="ncit0012" npl-type="s"><text>Marin et al., Proc. Natl. Acad. Sci. USA, 81, 337 1984</text></nplcit>), cerulenin resistance gene (<i>fas2m</i>, <i>PDR4</i>) (<nplcit id="ncit0013" npl-type="s"><text>Junji Inokoshi et al., Biochemistry, vol. 64, p. 660, 1992</text></nplcit>; <nplcit id="ncit0014" npl-type="s"><text>Hussain et al., gene, 101, 149, 1991</text></nplcit>) and so on.</p><p id="p0052" num="0052">For transformation of host cells, commonly used known techniques can be used. For example, in the case of prokaryotic organisms, electroporation (<nplcit id="ncit0015" npl-type="s"><text>Mackenxie D. A. et al. Appl. Environ. Microbiol., 66, 4655-4661, 2000</text></nplcit>) or heat shock method may be used for transformation. Likewise, in the case of yeast, transformation may be accomplished by, but is not limited to, electroporation, spheroplast method (<nplcit id="ncit0016" npl-type="s"><text>Proc. Natl. Acad. Sci. USA, 75 p1929(1978</text></nplcit>)), lithium acetate method (<nplcit id="ncit0017" npl-type="s"><text>J. Bacteriology, 153, p163(1983</text></nplcit>)), <nplcit id="ncit0018" npl-type="s"><text>Proc. Natl. Acad. Sci. USA, 75 p1929 (1978</text></nplcit>), and other methods as described in Methods in yeast genetics, 2000 Edition: A Cold Spring Harbor Laboratory Course Manual.</p><p id="p0053" num="0053">In addition, as for standard cloning techniques, reference may be made to "<nplcit id="ncit0019" npl-type="b"><text>Sambrook &amp; Russell, Molecular Cloning: A Laboratory Manual Vol. 3, Cold Spring Harbor Laboratory Press 2001</text></nplcit>," "<nplcit id="ncit0020" npl-type="b"><text>Methods in Yeast Genetics, A laboratory manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY</text></nplcit>)," etc.</p><heading id="h0012">3. Method for producing ethanol</heading><p id="p0054" num="0054">The microorganism of the present invention prepared as above has increased xylose fermentation ability in comparison with a wild-type microorganism of the same species. As used herein, the term "xylose fermentation" is intended to mean that ethanol is produced by assimilation of xylose. Namely, xylose fermentation refers to ethanol fermentation from xylose. Ethanol fermentation refers to a reaction in which ethanol is produced through the fermentation process.<br/>
Thus, when cultured in the presence of xylose-containing raw materials, the microorganism of the present invention shows reduced production of by-products, i.e., xylitol and glycerol, in comparison with a wild-type microorganism of the same species which is cultured under the same conditions. As a consequence, more ethanol is produced by the microorganism of the present invention.<br/>
Based on this finding, the present invention provides, in another embodiment, a method for producing ethanol, which comprises a step of contacting the microorganism of the present invention with xylose-containing raw materials.</p><p id="p0055" num="0055">The step of contacting the microorganism of the present invention with xylose-containing materials may be accomplished by mixing the microorganism of the present<!-- EPO <DP n="19"> --> invention with xylose-containing materials. Preferably, the microorganism of the present invention is contacted in an active state with xylose-containing materials.<br/>
Examples of techniques for contacting the microorganism of the present invention in an active state with xylose-containing materials include those for culturing the microorganism of the present invention under culture conditions allowing the microorganism of the present invention to grow and in the presence of xylose-containing raw materials. Such culture conditions will vary depending on the species of microorganism. For example, in the case of yeast, culture may be accomplished at 30°C in an appropriate medium, e.g., YPD medium (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glucose), SX medium (50 g/l xylose, 6.7 g/l yeast nitrogen base free from amino acids, 20 mg/l adenine, 20 mg/l histidine, 100 mg/l leucine, 20 mg/l tryptophan), which is supplemented with xylose-containing raw materials.<br/>
Alternatively, prior to culture in the presence of xylose-containing raw materials, the microorganism of the present invention may be cultured to increase the number of microbial cells under culture conditions allowing the microorganism of the present invention to grow, followed by fermentation with the microorganism of the present invention in the presence of xylose-containing raw materials.<br/>
However, culture conditions are not limited to those mentioned above. Those skilled in the art would be able to select suitable culture conditions as appropriate for the species of microorganism and to actually culture the microorganism.</p><p id="p0056" num="0056">The xylose fermentation ability can be confirmed by contacting the microorganism of the present invention with xylose-containing raw materials and, after passing a certain period of time, measuring ethanol production level in the system.<br/>
Moreover, the xylose fermentation ability can also be measured as the yield of ethanol relative to xylose assimilation level. The yield of ethanol relative to xylose assimilation level can be calculated as follows.<br/>
First, the production of ethanol (C<sub>2</sub>H<sub>5</sub>OH) from xylose (C<sub>5</sub>H<sub>10</sub>O<sub>5</sub>) is represented by the following reaction scheme.<br/>
<br/>
        6 C<sub>5</sub>H<sub>10</sub>O<sub>5</sub> → 10 C<sub>2</sub>H<sub>5</sub>OH + 10 CO<sub>2</sub> + 10 ATP<br/>
<br/>
</p><p id="p0057" num="0057">Based on this reaction scheme as well as xylose molecular weight (150) and ethanol molecular weight (46), the relationship represented by the following equation can be established between xylose assimilation level and ethanol production level. <maths id="math0005" num=""><math display="block"><mi>Ethanol production level</mi><mo>=</mo><mi>xylose assimilation level</mi><mo>×</mo><mfenced open="{" close="}" separators=""><mfenced separators=""><mn>10</mn><mo>×</mo><mn>46</mn></mfenced><mo>/</mo><mfenced separators=""><mn>6</mn><mo>×</mo><mn>150</mn></mfenced></mfenced></math><img id="ib0005" file="imgb0005.tif" wi="130" he="5" img-content="math" img-format="tif"/></maths></p><p id="p0058" num="0058">Thus, the case where ethanol is produced in an amount of "xylose assimilation level × {(10 × 46)/(6 × 150)} = xylose assimilation level × 0.51" can be set to 100% ethanol yield.<!-- EPO <DP n="20"> --></p><p id="p0059" num="0059">Xylose assimilation level and ethanol production level can be easily determined when the fermentation system containing the microorganism of the present invention and xylose-containing raw materials is analyzed for ingredients by known analysis procedures such as high performance liquid chromatography, etc.</p><p id="p0060" num="0060">"Xylose-containing raw materials" are not limited in any way as long as they are raw materials containing xylose. Preferred are raw materials derived from xylose-containing organisms, i.e., "xylose-containing biomass." Biomass is defined as "renewable, organism-derived organic resources, excluding fossil resources" in the "<nplcit id="ncit0021" npl-type="b"><text>Biomass Nippon Strategy" published by the Japanese Ministry of Agriculture, Forestry and Fisheries</text></nplcit>.<br/>
Accordingly, based on this definition, the term "xylose-containing biomass" can be defined as "renewable, organism-derived organic resources containing xylose, excluding fossil resources."<br/>
Specific examples of xylose-containing biomass include, but are not limited to, non-edible parts of sugar cane, maize, beet, potato, sweet potato, wheat, kaoliang (<i>Sorghum</i>)<i>,</i> sorghum and so on, as well as scrap wood, pulp spent liquor, bagasse, chaff, corncob, rice straw, switchgrass, Erianthus, napier grass, etc.</p><heading id="h0013">EXAMPLES</heading><p id="p0061" num="0061">The present invention will be further described in more detail by way of the following illustrative examples, although the present invention is not limited to the embodiments disclosed herein.</p><heading id="h0014">Test methods:</heading><p id="p0062" num="0062">The test items and test methods used in the following examples are shown below. Unless otherwise specified, the test methods in the examples illustrated below were in accordance with the following.</p><heading id="h0015">&lt;Obtaining of <i>UTR1</i> and <i>YEF1</i> genes&gt;</heading><p id="p0063" num="0063">Yeast <i>Saccharomyces cerevisiae UTR1</i> gene has already been cloned and its nucleotide sequence has been reported (Saccharomyces Genome Database Accession No. YJR049C). Likewise, yeast <i>Saccharamyces cerevisiae YEF1</i> gene has also already been cloned and its nucleotide sequence has been registered in the Genbank (Genbank Accession No. NM_001178856). Thus, the <i>UTR1</i> gene (genome sequence: SEQ ID NO: 1) and the <i>YEF1</i> gene (genome sequence: SEQ ID NO: 3) can be obtained based on their nucleotide sequence information by being PCR amplified and isolated using, as PCR templates, chromosomal DNAs prepared from yeast <i>Saccharomyces cerevisiae</i> having the respective genes. More specifically, in this case, chromosomal<!-- EPO <DP n="21"> --> DNAs of yeast <i>Saccharomyces cerevisiae</i> X2180-1A (ATCC26786) (<i>MATa SUC2 mal mel gal2 CUP1</i>) were used as templates in PCR with primers UTR1F1 and UTR1R1 to obtain <i>UTR1</i> and with primers YEFIF1 and YEF1R1 to obtain <i>YEF1</i>. Using Invitrogen pENTR<sup>™</sup> Directional TOPO Cloning Kits, the obtained DNA fragments were each inserted into a vector, pENTR<sup>™</sup>/D-TOPO<sup>®</sup>, to thereby obtain plasmid pENTUTR1 (<figref idrefs="f0002">Figure 2</figref>) or pENTYEF1 (<figref idrefs="f0003">Figure 3</figref>). The inserted genes were both confirmed for their sequences by DNA sequencing. The chromosomal DNAs used for obtaining both genes are not limited to the strain mentioned above and may be prepared from any yeast strain as long as it belongs to <i>Saccharomyces cerevisiae.</i> PCR amplification of the target genes from chromosomal DNAs and the subsequent isolation thereof, including preparation of PCR primers, may be accomplished in a manner well known to those skilled in the art.
<ul><li>UTR1F1:
<ul><li>5' CACCGTTTAAACTCTAGAATGAAGGAGAATGACATGAATAAT 3' (SEQ ID NO: 5)</li></ul></li><li>UTR1R1:
<ul><li>5' GTTTAAACGGATCCTTATACTGAAAACCTTGCTTGAGA 3' (SEQ ID NO: 6)</li></ul></li><li>YEF1F1:
<ul><li>5' CACCGTTTAAACTCTAGAATGAAAACTGATAGATTACTGATTA 3' (SEQ ID NO: 7)</li></ul></li><li>YEF1R1:
<ul><li>5' GTTTAAACGAGCTCTTAGATTGCAAAATGAGCCTGAC 3' (SEQ ID NO: 8)</li></ul></li></ul></p><heading id="h0016">&lt;Procedures for preparation of template DNA for PCR&gt;</heading><p id="p0064" num="0064">Yeast cells were suspended in 50 µl of Lysis buffer (0.125 mg/ml zymolyase 100T, 1 M sorbitol, 40 mM potassium phosphate buffer pH 6.8, 1 mM dithiothreitol). After incubation at 30°C for 1 hour, 5 µl of protease E (1 mg/ml) was added and the suspension was further incubated at 55°C for 20 minutes and at 99°C for 10 minutes. The suspension was centrifuged at 15,000 rpm for 10 minutes and the resulting supernatant was used as template DNA.</p><heading id="h0017">&lt;Unit preparation for <i>UTR1</i> or <i>YEF1</i> gene disruption&gt;</heading><p id="p0065" num="0065">For <i>UTR1</i> gene disruption, the <i>UTR1</i> gene in pENTUTR1 was cleaved with BsaAI and FspI, into which G418 resistance marker gene (<i>PGK1</i>p::<i>KanMX</i>) excised with Pmel from plasmid pYRGFLP (<figref idrefs="f0004">Figure 4</figref>) was then inserted to obtain plasmid pENTUTR1G (<figref idrefs="f0006">Figure 6</figref>). For <i>YEF1</i> gene disruption, the <i>YEF1</i> gene in pENYEF1 was cleaved with BstEII and StuI, into which Nat resistance marker gene (<i>TEF1</i>p::<i>NatMX</i>) excised with PmeI from plasmid pYRNFLP (<figref idrefs="f0005">Figure 5</figref>) was then inserted to obtain<!-- EPO <DP n="22"> --> plasmid pENTYEFIN (<figref idrefs="f0007">Figure 7</figref>). This pENTUTR1G or pENTYEF1N was cleaved with PmeI and electrophoresed on an agarose gel, followed by excising a DNA fragment of approximately 3.3 kbp (having N-terminal and C-terminal partial sequences from <i>UTR1</i> and comprising G418 resistance marker gene (<i>PGK1</i>p::<i>KanMX</i>) in the center) or a DNA fragment of approximately 2.1 kbp (having N-terminal and C-terminal partial sequences from <i>YEF1</i> and comprising Nat resistance marker gene <i>(TEF1p::NatMX)</i> in the center) from the agarose gel. These DNA fragments were purified and extracted from the gel. Their purification and extraction were accomplished by using an illustra<sup>™</sup> GFX<sup>™</sup> PCR DNA and Gel Band Purification kit in accordance with the instruction manual.</p><heading id="h0018">&lt;Yeast strains&gt;</heading><p id="p0066" num="0066">In the present invention, <i>S. cerevisiae</i> strain X2180-1A was used for obtaining of <i>UTR1</i>, while <i>S</i>. <i>cerevisiae</i> strains HH467, 468, 472 and 473 were used for breeding of <i>UTR1</i> disruptants. For breeding of <i>YEF1</i> disruptants, <i>S</i>. <i>cerevisiae</i> strain HH472 was used. In all strains used for the above purposes, expression units for <i>P. stipitis</i> xylose reductase gene (<i>XYL1</i>; SEQ ID NO: 9), <i>P. stipitis</i> xylitol dehydrogenase gene (<i>XYL2</i>; SEQ ID NO: 11) and <i>S</i>. <i>cerevisiae</i> xylulose kinase gene (<i>XKS1</i>; SEQ ID NO: 13) were integrated into certain regions in the chromosome under the control of promoters as shown for their genotypes, without being limited thereto.
<ol><li>(1) <i>S</i>. <i>cerevisiae</i> X2180-1A (ATCC26786) <i>(MATa SUC2 mal mel gal2 CUP1</i>)</li><li>(2) <i>S. cerevisiae</i> HH467 <i>(MATa leu2-3,112 trpI-1 his3-11,15 ade2-1 canal-100 rad5-535 ura3-1::URA3::TDH3p::XYL1::TDH3p::XYL2::TDH3p::XKS1</i>)</li><li>(3) <i>S. cereviszae</i> HH468 (<i>MATa ade1 MAL61 MAL62 MAL63 AGT1 MAL12 MAL31 MAL32 ura3::URA3::TDH3p::XYL1::TDH3p::XYL2::TDH3p:.XKS1</i>)</li><li>(4) <i>S. cerevisiae</i> HH472 <i>(MATa SUC2 mal mel gal2 CUP1 GATI::TDH3p::XYL1::PYK1p::XYL2::TPI1p::XKS1)</i></li><li>(5) <i>S. cerevisiae</i> HH473 (<i>MATa SUC2 mal mel gal2 CUP1 YCT1::TDH3p::XYL1::PYK1p::XYL2::TPI1p::XKS1)</i></li><li>(6) <i>S. cerevisiae</i> CB11 (Berkley Stock Center) <i>(MATa ade1 MAL61 MAL62 MAL63 AGT1 MAL12 MAL31 MAL32)</i></li><li>(7) <i>S. cerevisiae</i> W303-1A (BY4848) (<i><u>MATa ura3</u>-1 <u>leu2</u>-3,112 <u>trpI</u>-1 <u>his3</u>-11,15 <u>ade2</u>-1 <u>can1</u>-100 <u>rad5</u>-535)</i></li></ol></p><p id="p0067" num="0067">Among the above strains, (6) is the parent strain of HH468 and (7) is the parent strain of HH467, both of which are commercially available ((6): deposited under FERM BP-4198 with the Fermentation Research Institute, the Agency of Industrial Science and Technology, (7): NBRP ID No. BY4848). Likewise, (1) is the parent strain of HH472 and HH473 and is commercially available (ATCC ID No. ATCC26786). The respective strains are shown along with their genotypes.<!-- EPO <DP n="23"> --></p><heading id="h0019">&lt;Breeding of <i>UTR1</i> or <i>YEF1</i> gene disruptants&gt;</heading><p id="p0068" num="0068">HH467, 468, 472 and 473 were transformed with the prepared DNA fragment of approximately 3.3 kbp (having N-terminal and C-terminal partial sequences from <i>UTR1</i> and comprising geneticin resistance gene (<i>PGK1</i>p<i>::KanMX)</i> in the center) or of approximately 2.1 kbp (having N-terminal and C-terminal partial sequences from <i>YEF1</i> and comprising Nat resistance marker gene (<i>TEF1</i>p<i>::NatMX</i>) in the center), and then applied onto a 300 µg/ml geneticin-containing YPD (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glucose* (added after being sterilized by filtration*)) medium for <i>UTR1</i> disruptants or applied onto a 50 µg/ml clonNAT (nourseothricin dihydrogen sulfate)-containing YPD (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glucose* (added after being sterilized by filtration*)) medium for <i>YEF1</i> disruptants. Some of the grown colonies were subjected to PCR with primers upUTR1_F1 and pPGK657-r1 or with primers downUTR1_R and G418_F1 for <i>UTR1</i> disruptants to verify fragment amplification, thereby confirming that the <i>UTR1</i> gene was disrupted. For <i>YEF1</i> disruptants, PCR was performed with primers YEF1U_F and natMX-r2 or with primers YEF1D_R and natMX-f2, to verify fragment amplification, thereby confirming that the <i>YEF1</i> gene was disrupted. Further, the transformants were applied onto YPGly (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glycerol) medium to verify their growth, thereby confirming that they were not respiratory deficient strains. In the embodiments illustrated here, the geneticin resistance or clonNAT resistance marker gene is used as a marker, although other markers may also be used depending on the genotype of host. When using a gene for complementation of the host's auxotrophy, e.g., <i>URA3</i>, selection can be conducted on a uracil-free agar medium. Alternatively, when using <i>YAP1</i>, a drug resistance gene against cycloheximide, selection can be conducted on a cycloheximide-containing YPD medium.
<tables id="tabl0005" num="0005"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="26mm"/><colspec colnum="2" colname="col2" colwidth="79mm"/><tbody><row><entry>upUTR1_F1:</entry><entry>5' CTACGCAAAGAGAACGGAG 3' (SEQ ID NO: 15)</entry></row><row><entry>pPGK657-r1:</entry><entry>5' GCAATCAATAGGAAGACAGG 3' (SEQ ID NO: 16)</entry></row><row><entry>downUTR1_R:</entry><entry>5' ATGTCACGCTTACATTCACG 3' (SEQ ID NO: 17)</entry></row><row><entry>G418_F1:</entry><entry>5' TGGTTGTAACACTGGCAGAG 3' (SEQ ID NO: 18)</entry></row><row><entry>YEF1U_F:</entry><entry>5' AGCGTTGTGAAAGGGAAATG 3' (SEQ ID NO: 19)</entry></row><row><entry>natMX-r2:</entry><entry>5' GTGTCGTCAAGAGTGGTACC 3' (SEQ ID NO: 20)</entry></row><row><entry>YEF1D_R:</entry><entry>5' TCTTCGACACTGCAAACGAC 3' (SEQ ID NO: 21)</entry></row><row><entry>natMX-f2:</entry><entry>5' TCTACATGAGCATGCCCTGC 3' (SEQ ID NO: 22)</entry></row></tbody></tgroup></table></tables></p><heading id="h0020">&lt;Xylose fermentation test on a small scale&gt;</heading><p id="p0069" num="0069">In this xylose fermentation test, the fermentation test medium used was YPX (10 g/L yeast extract, 20 g/L polypeptone, 50 g/L xylose* (added after being sterilized separately*)) or CSLX (0.5% corn steep liquor, 5 g/L urea**, 1 mg/L pyridoxal hydrochloride**, 1 mg/L thiamine hydrochloride**, 0.1 mg/L biotin**, 10 mg/L<!-- EPO <DP n="24"> --> pantothenic acid**, 1 mg/L magnesium sulfate, 2 mg/L zinc sulfate, 50 g/L xylose*, pH 5.0 (added after being sterilized by filtration**, added after being sterilized separately*)). Yeast provided for the fermentation experiment was cultured as follows. A loopful of test yeast was inoculated into YPD (10 ml) and cultured in an incubator at 30°C for 20 hours under shaking conditions. From the cultured solution, the yeast cells were collected and then suspended in fresh YPD (20 ml) and cultured at 30°C for 3 hours under shaking conditions. The yeast cells were collected and washed twice with the medium to be used for the fermentation test, and then inoculated into 2 ml of the medium at OD<sub>600</sub> = 20 or OD<sub>600</sub> = 25. The suspension was transferred to a microtube of 3 ml volume and capped, followed by incubation at 30°C. Aliquots were sampled as appropriate, centrifuged and filtered, followed by high performance liquid chromatography to analyze their ingredients.</p><heading id="h0021">&lt;Xylose fermentation test on a large scale&gt;</heading><p id="p0070" num="0070">In this fermentation test using a medium bottle of 100 ml volume, a silicon tube of 4 mm inner diameter was inserted through the cap of the bottle. The length of the tube was adjusted such that the tube was not immersed in the medium. The tube was equipped with a check valve through which gases would escape when the internal pressure was elevated, whereby the pressure would be able to be adjusted to the same level as the external pressure. Yeast provided for the fermentation test was cultured as follows. A loopful of test yeast was inoculated into YPD (10 ml) and cultured in an incubator at 30°C for 20 hours under shaking conditions. The cultured solution was inoculated in its entirety into YPD (100 ml) in a 300 ml Erlenmeyer flask and cultured in an incubator at 30°C for 20 hours under shaking conditions, followed by centrifugation to collect all the yeast cells. The yeast cells were suspended again in YPD (200 ml) in a 500 ml Erlenmeyer flask and cultured at 30°C for 6 hours under shaking conditions. The yeast cells were collected and washed twice with the medium to be used for the fermentation test, and then inoculated into 45 ml of the medium at OD<sub>600</sub> = 20. The medium bottle was soaked in a water bath until reaching the depth of the medium and was kept at a temperature of 30°C to effect fermentation while stirring at a rate of 60 rpm with a sterile stirrer bar. 1 ml aliquots of the fermented mash were sampled as appropriate, centrifuged and filtered, followed by high performance liquid chromatography to analyze their ingredients.</p><heading id="h0022">&lt;Xylose fermentation test in serial batch fermentation mode&gt;</heading><p id="p0071" num="0071">Yeast from the fermentation test conducted on a 45 ml scale was collected by centrifugation, inoculated into 10 ml of CSLX medium at OD<sub>600</sub> = 100 and then transferred to a capped sterile plastic tube of 50 ml volume to effect fermentation at 30°C. After 48 hours, 1 ml of the fermented mash was sampled, centrifuged and filtered, followed by high performance liquid chromatography to analyze its ingredients. The remainder of the yeast was collected in its entirety and used for the next round of<!-- EPO <DP n="25"> --> fermentation to conduct a fermentation test in the same manner.</p><heading id="h0023">&lt;Measurement of ethanol, xylose, glycerol and xylitol&gt;</heading><p id="p0072" num="0072">From the fermented mash, aliquots were sampled as appropriate, centrifuged and filtered. The supernatants were each quantified by high performance liquid chromatography under the conditions shown below. The concentrations of ingredients in the test samples were calculated from the peak areas of their respective pure samples at known concentrations.
<ol><li>(1) Separation column and conditions<br/>
Column: Shodex SUGAR SH-G (6.0 × 50 mm) + SH1011 (8.0 × 300 mm)<br/>
Eluent: 5 mM H<sub>2</sub>SO<sub>4</sub><br/>
Flow rate: 0.6 ml/min<br/>
Column oven: 60°C<br/>
Detector:
<ul><li>diode array detector (DAD) 280 nm (for furfurals)</li><li>differential refractive index detector (RI) (for other sugars)</li></ul></li><li>(2) System configuration<br/>
HPLC main unit: Hitachi L-2000 series<br/>
Pump: L-2130<br/>
Autosampler: L-2200<br/>
DAD detector: L-2450<br/>
RI detector: L-2490<br/>
Column oven: Shimadzu CTO-10A</li></ol></p><heading id="h0024"><u>Example 1: Xylose fermentation test on <i>UTR1</i> disruptants in YPX medium (1)</u></heading><p id="p0073" num="0073">HH467 and HH468 were used as hosts to breed <i>UTR1</i> disruptants. For each case, the parent strain (n = 1) and three bred strains (n = 2) were each cultured in YPD as described in the test methods, inoculated into YPX medium (2 ml) at OD<sub>600</sub> = 20, and then transferred to a microtube to conduct a fermentation test at 30°C under static conditions. After 24 hours, the yeast cells were separated by centrifugation and the supernatant was quantified for ethanol and xylose by high performance liquid chromatography. The yield of ethanol was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The results obtained are shown in <figref idrefs="f0008">Figures 8</figref> and <figref idrefs="f0009">9</figref>. In either case of using HH467 or HH468 as a host, the <i>UTR1</i> disruptants showed an increase in the yield of ethanol produced from xylose when compared to their parent strains. Moreover, their xylose assimilation levels were almost the same as those of their parent strains. It can be confirmed that <i>UTR1</i> disruption is effective in increasing the yield of ethanol produced from xylose.<!-- EPO <DP n="26"> --></p><heading id="h0025"><u>Example 2: Xylose fermentation test on <i>UTR1</i> disruptants in YPX medium (2)</u></heading><p id="p0074" num="0074">HH473 was used as a host to breed a <i>UTR1</i> disruptant. The strain HH473 is a strain bred from X2180-1A and is not auxotrophic unlike HH467 and HH468. For each case, one strain was cultured in YPD as described in the test methods, inoculated into YPX medium (2 ml) at OD<sub>600</sub> = 25, and then transferred to a microtube to conduct a fermentation test at 30°C under static conditions. After 24 or 48 hours, the yeast cells were separated by centrifugation and the supernatant was quantified for ethanol and xylose by high performance liquid chromatography. The yield of ethanol was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The results obtained are shown in <figref idrefs="f0010">Figure 10</figref>. Even in the case of HH473 which is not auxotrophic for amino acids, the <i>UTR1</i> disruptant showed an increase in the yield of ethanol produced from xylose when compared to its parent strain. The levels of by-products, i.e., xylitol and glycerol measured after 48 hours are also shown along with ethanol (<figref idrefs="f0011">Figure 11</figref>). In the <i>UTR1</i> disruptant, xylitol production level was significantly lower than in the parent strain.<br/>
Next, the strain HH472 was used as a host to obtain a <i>UTR1</i> disruptant. The strain HH472 differs from the strain HH473 in the region where the expression cassette <i>TDH3p::XYL1::PYK1p::XYL2::TPI1p::XKS1</i> is inserted.<br/>
To confirm reproducibility, the same fermentation test as above was conducted at n = 2 for the parent strain and at n = 8 for the <i>UTR1</i> disruptant As a result, the <i>UTR1</i> disruptant showed significantly high ethanol yield (<figref idrefs="f0012">Figure 12</figref>), whereas its xylitol production level was low (<figref idrefs="f0013">Figure 13</figref>).</p><heading id="h0026"><u>Example 3: Xylose fermentation test on <i>UTR1</i> disruptants in CSLX medium</u></heading><p id="p0075" num="0075">The <i>UTR1</i> disruptant bred from HH472 as a parent strain in Example 2 (n = 8) and the parent strain (n = 2) were used to conduct a fermentation test in CSLX medium. After being cultured in YPD as described in the test methods, each strain was inoculated into CSLX medium (2 ml) at OD<sub>600</sub> = 25 and then transferred to a microtube to conduct a fermentation test at 30°C under static conditions. After 24 or 48 hours, the yeast cells were separated by centrifugation and the supernatant was quantified for ethanol, xylose, xylitol and glycerol by high performance liquid chromatography. The yield of ethanol was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The production level and yield of ethanol are shown in <figref idrefs="f0014">Figure 14</figref>. The <i>UTR1</i> disruptant showed a significant increase in the yield of ethanol produced from xylose when compared to its parent strain. The levels of by-products, i.e., xylitol and glycerol measured after 48 hours are also shown along with ethanol (<figref idrefs="f0015">Figure 15</figref>). Both levels were lower than in the parent strain. In light of the fact that degradation products of biomass are substantially free from amino acids, it can be regarded as a particularly important result that a similar effect was observed even in CSLX medium whose amino acid content is only about one-fourth of that in YPX. This result indicates that the microorganism of the present<!-- EPO <DP n="27"> --> invention is useful for ethanol production starting from xylose-containing biomass.</p><heading id="h0027"><u>Example 4: Xylose fermentation test on <i>UTR1</i> disruptants in CSLX medium on a 45 ml scale</u></heading><p id="p0076" num="0076">The <i>UTR1</i> disruptant bred from HH472 as a parent strain in Example 2 and the parent strain were each cultured in YPD as described in the test methods at n = 2 for the parent strain and at n = 5 for the <i>UTR1</i> disruptant, and then inoculated into CSLX medium (45 ml) in a 100 ml medium bottle at OD<sub>600</sub> = 20. At 30°C, a fermentation test was conducted while stirring with a magnet stirred (60 rpm). After 3, 20, 27, 44 and 51 hours, aliquots were sampled, centrifuged to separate the yeast cells, and then quantified for ethanol, xylose, xylitol and glycerol by high performance liquid chromatography. The yield of ethanol was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The time courses of individual ingredients are shown in <figref idrefs="f0016 f0017 f0018 f0019">Figures 16 to 19</figref>. The <i>UTR1</i> disruptant showed a reduction in the production levels of xylitol and glycerol and showed an increase in the production level and yield of ethanol when compared to the parent strain. Moreover, the speed of xylose assimilation was the same as in the parent strain. In the case of fermentation under stirring conditions without aeration, <i>UTR1</i> disruption was also found to cause a reduction in the production levels of xylitol and glycerol, which are by-products of ethanol fermentation, and an increase in the production level of ethanol.</p><heading id="h0028"><u>Example 5: Serial batch xylose fermentation test on <i>UTR1</i> disruptants in CSLX medium on a 10 ml scale</u></heading><p id="p0077" num="0077">The parent strain (n = 2) and the <i>UTR1</i> disruptant (n = 5) from the fermentation test conducted on a 45 ml scale in Example 4 were each collected by centrifugation, inoculated into 10 ml of CSLX medium at OD<sub>600</sub> = 100 and then transferred to a capped sterile plastic tube of 50 ml volume to effect fermentation at 30°C under static conditions. After 48 hours, aliquots were sampled, centrifuged, filtered and then quantified for ethanol, xylose, xylitol and glycerol by high performance liquid chromatography. The yield of ethanol was calculated as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. Yeast cells in the remainder of the fermented mash were collected in their entirety and used for the next round of fermentation in the same manner. The fermentation was repeated three times in succession. <figref idrefs="f0020">Figure 20</figref> shows the yield of ethanol production, <figref idrefs="f0021">Figure 21</figref> shows xylose assimilation level, <figref idrefs="f0022">Figure 22</figref> shows xylitol production level, and <figref idrefs="f0023">Figure 23</figref> shows glycerol production level. Even in the case of repeating fermentation in succession, the <i>UTR1</i> disruptant was higher in both the production level of ethanol and the yield of ethanol than the parent strain. In particular, the yield of ethanol tended to decrease in the parent strain with increase in the number of fermentation rounds, whereas the yield of ethanol conversely tended to increase in<!-- EPO <DP n="28"> --> the <i>UTR1</i> disruptant. Moreover, the production levels of by-products, i.e., xylitol and glycerol were low even in the case of serial batch fermentation. Xylose assimilation level was found to slightly decrease with increase in the number of fermentation rounds, although this tendency was also seen in the parent strain. This result indicated that the <i>UTR1</i> disruptant produced the same effect even in serial batch fermentation. In ethanol production from biomass, the property of being fermentable in a continuous manner is significantly meaningful because it is very important to reduce the production costs.</p><heading id="h0029"><u>Example 6: Xylose fermentation test on <i>UTR1, YEF1</i> and <i>UTR1YEF1</i> disruptants in YPX medium</u></heading><p id="p0078" num="0078"><i>UTR1, YEF1</i> and <i>UTR1 YEF1</i> disruptants prepared using HH472 as a host were bred. The strain HH472 is a strain bred from X2180-1A and is not auxotrophic unlike HH467 and HH468. The parent strain (n = 2), the <i>UTR1</i> disruptant (n = 2), the <i>YEF1</i> disruptant (n = 3) and the <i>UTR1 YEF1</i> disruptant (n = 4) were each cultured in YPD as described in the test methods, inoculated into YPX medium (2 ml) at OD<sub>600</sub> = 25, and then transferred to a microtube and allowed to stand at 30°C to conduct a fermentation test. After 24 or 48 hours, the yeast cells were separated by centrifugation and the supernatant was quantified for ethanol and xylose by high performance liquid chromatography. The yield of ethanol was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The results obtained are shown in <figref idrefs="f0024">Figure 24</figref>. The <i>UTR1</i> disruptant showed an increase in the yield of ethanol produced from xylose when compared to the parent strain. The <i>YEF1</i> disruptant showed only a slight increase in the yield of ethanol produced from xylose when compared to the parent strain, whereas the <i>UTR1 YEF1</i> disruptant, in which both <i>UTR1</i> and <i>YEF</i> genes were disrupted, showed a greater increase in the yield of ethanol than the <i>UTR1</i> disruptant. The levels of by-products, i.e., xylitol and glycerol measured after 48 hours are also shown along with ethanol in <figref idrefs="f0025">Figure 25</figref>. The <i>UTR1 YEF1</i> disruptant achieved lower production levels of xylitol and glycerol and a higher production level of ethanol than the <i>UTR1</i> disruptant. Disruption of both <i>UTR1</i> and <i>YEF1</i> genes was found to achieve a higher effect.</p><heading id="h0030">&lt;Conclusion&gt;</heading><p id="p0079" num="0079">As described above, it was found that NADH reoxidation reaction limited the rate of ethanol fermentation from xylose. This finding indicates that the yield of ethanol can be increased upon disruption of NAD kinase <i>UTR1</i> gene and/or <i>YEF1</i> gene. The microorganism of the present invention can be prepared as a strain that is either auxotrophic or not auxotrophic for amino acids which require NAD and/or NADPH for their synthesis, and the thus prepared microorganisms can exert the same effect when used in xylose fermentation. Moreover, in cases where the microorganism of the present invention is used for xylose fermentation, a high fermentation effect can be<!-- EPO <DP n="29"> --> observed either in a nutrient-rich medium such as YPX or in an industrially used nutrient-poor medium such as com steep liquor and urea (CSLX).</p><heading id="h0031"><u>Example 7: Preparation of <i>FPS1</i> disruptant</u></heading><heading id="h0032">&lt;Obtaining <i>of FPS1</i> gene&gt;</heading><p id="p0080" num="0080">Yeast <i>Saccharomyces cerevisiae FPS1</i> gene (SEQ ID NO: 23) has already been reported as to its nucleotide sequence (Saccharomyces Genome Database Accession No. <i>YLL043W</i>). In addition, the amino acid sequence of <i>FPS1</i> protein encoded by this gene is shown in SEQ ID NO: 24.<br/>
Based on its nucleotide sequence information, the <i>FPS1</i> gene can be obtained by being PCR amplified and isolated using, as a PCR template, chromosomal DNA prepared from yeast <i>Saccharomyces cerevisiae.</i> More specifcally, in this example, chromosomal DNA of yeast <i>Saccharomyces cerevisiae</i> X2180-1A (ATCC26786) <i>(MATa SUC2 mal mel gal2 CUP1</i>) was used as a template in PCR with primers FPS1NFSCXB and FPS 1 CRB shown below to obtain <i>FPS1</i>. Using an Invitrogen TOPO TA Cloning<sup>®</sup> Kit for sequencing, the obtained DNA fragment was inserted into a vector, pCR<sup>®</sup> 4-TOPO, to thereby obtain plasmid pCR4FPS1 (<figref idrefs="f0026">Figure 26</figref>). The inserted genes were both confirmed for their sequences by DNA sequencing. The chromosomal DNAs used for obtaining both genes are not limited to the strain mentioned above and may be prepared from any yeast strain as long as it belongs to <i>Saccharomyces cerevisiae.</i> PCR amplification of the target genes from chromosomal DNAs and the subsequent isolation thereof, including preparation of PCR primers, may be accomplished in a manner well known to those skilled in the art.
<tables id="tabl0006" num="0006"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="26mm"/><colspec colnum="2" colname="col2" colwidth="104mm"/><tbody><row><entry>FPS1NFSCXB:</entry><entry>5' GAGCTCTAGAATGAGTAATCCTCAAAAAGCTC 3' (SEQ ID NO: 25)</entry></row><row><entry>FPS1CRB:</entry><entry>5' GGATCCTCATGTTACCTTCTTAGCATTAC 3' (SEQ ID NO: 26)</entry></row></tbody></tgroup></table></tables></p><heading id="h0033">&lt;Unit preparation for <i>FPS1</i> gene disruption&gt;</heading><p id="p0081" num="0081">To prepare a unit for <i>FPS1</i> gene disruption, the <i>FPS1</i> gene in pCR4FPS1 was cleaved with StuI and <i>Hinc</i>II and then blunted. AUR (aureobasidin) resistance marker gene (<i>TDH3</i>p::<i>AUR1-C</i>) excised with <i>Kpn</i>I and <i>Fsp</i>I from plasmid pYRAFLP (<figref idrefs="f0027">Figure 27</figref>) was inserted into this site to obtain plasmid pCR4FPS1AUR (<figref idrefs="f0028">Figure 28</figref>). This pCR4FPS1AUR was cleaved with <i>Pme</i>I and <i>Not</i>I and then electrophoresed on an agarose gel, followed by excising a DNA fragment of approximately 4.0 kbp (having N-terminal and C-terminal partial sequences from <i>FPS1</i> and comprising aureobasidin resistance marker gene (<i>TDH3</i>p::<i>AUR1-C</i>) in the center) from the agarose gel. The DNA fragment was purified and extracted from the gel. Its purification and extraction were accomplished by using an illustra<sup>™</sup> GFX<sup>™</sup> PCR DNA and Gel Band Purification kit in accordance with the instruction manual.<!-- EPO <DP n="30"> --></p><heading id="h0034">&lt;Breeding <i>of FPS1</i> gene disruptants&gt;</heading><p id="p0082" num="0082">HH472 or a disruptant thereof, in which either or both of the <i>UTR1</i> gene and the <i>YEF1</i> gene were disrupted, was transformed with the prepared DNA fragment of approximately 4.0 kbp (having N-terminal and C-terminal partial sequences from <i>FPS1</i> and comprising aureobasidin resistance gene (<i>TDH3</i>p::<i>AUR1-C</i>) in the center), and then applied onto a 2 µg/ml aureobasidin-containing YPD (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glucose* (added after being sterilized by filtration*)) medium. Some of the grown colonies were subjected to PCR with primers FPS1PF1 and AUR1_R shown below to verify amplification of a 1631 bp fragment, thereby confirming that the <i>FPS1</i> gene was disrupted. Further, the transformants were applied onto YPGly (10 g/L yeast extract, 20 g/L polypeptone, 20 g/L glycerol) medium to verify their growth, thereby confirming that they were not respiratory deficient strains. In the embodiments illustrated here, the aureobasidin resistance marker gene is used as a marker, although other markers may also be used depending on the genotype of host. When using a gene for complementation of the host's auxotrophy, e.g., <i>URA3,</i> selection can be conducted on a uracil-free agar medium. Alternatively, when using <i>YAP1</i>, a drug resistance gene against cycloheximide, selection can be conducted on a cycloheximide-containing YPD medium.
<tables id="tabl0007" num="0007"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="19mm"/><colspec colnum="2" colname="col2" colwidth="83mm"/><tbody><row><entry>FPS1PF1:</entry><entry>5'ATAACGCCTATTGTCCCAATAAG 3' (SEQ ID NO: 27)</entry></row><row><entry>AUR1_R:</entry><entry>5' CATCTCGAAAAAGGGTTTGC 3' (SEQ ID NO: 28)</entry></row></tbody></tgroup></table></tables></p><heading id="h0035"><u>Example 8: Xylose fermentation test on <i>UTR1, YEF1, FPS1, UTR1 YEF1, UTR1 FPS1</i> and <i>UTR1 YEF1 FPS1</i> disruptants in YPD and YPX media</u></heading><p id="p0083" num="0083">Six disruptants <i>UTR1</i>, <i>YEF1</i>, <i>FPS1</i>, <i>UTR1 YEF1</i>, <i>UTR1 FPS1</i> and <i>UTR1 YEF1 FPS1</i> constructed using HH472 as a host and their parent strain HH472 were each cultured in YPD as described in the test methods, and then inoculated into YPX medium or YPD medium (2 ml) at OD<sub>600</sub> = 25 and transferred to a microtube to conduct a fermentation test at 30°C under static conditions (n = 3 for each strain). After 24 or 48 hours, the yeast cells were separated by centrifugation (sampled only after 24 hours in the case of fermentation in YPD), followed by high performance liquid chromatography to quantify ethanol, xylose, xylitol, glycerol and acetic acid in the case of xylose fermentation and to quantify ethanol, glucose, glycerol and acetic acid in the case of glucose fermentation. The yield of ethanol from xylose was expressed as a percentage, assuming that ethanol production in an amount of xylose assimilation level × 0.51 was set to 100% yield. The results obtained are shown in <figref idrefs="f0029">Figure 29</figref>. As in the case of the <i>UTR1</i> disruptant and the <i>YEF1</i> disruptants, the <i>FPS1</i> disruptant showed an increase in the yield of ethanol produced from xylose when compared to the parent strain (<figref idrefs="f0029">Figure 29</figref>). The levels of by-products, i.e., xylitol, glycerol and acetic acid measured after 48 hours are shown along with ethanol (<figref idrefs="f0030">Figure 30</figref>). The <i>FPS1</i> disruptant showed a slight increase in glycerol and acetic acid levels when compared to the parent strain, whereas<!-- EPO <DP n="31"> --> xylitol production level was lower than in the parent strain. The <i>UTR1 YEF1</i> disruptant, the <i>UTR1 FPS1</i> disruptant and the <i>UTR1 YEF1 FPS1</i> disruptant all showed a decrease in by-product production levels when compared to the single disruptants of these genes, and hence showed an increase in the yield of ethanol from xylose, thus indicating that the yield of ethanol from xylose can be effectively increased when these three genes are disrupted in any combination.<br/>
As in the case of xylose fermentation, the yield of ethanol from glucose was expressed as a percentage, assuming that ethanol production in an amount of glucose assimilation level × 0.51 was set to 100% yield. The results obtained are shown in <figref idrefs="f0031">Figure 31</figref> and <figref idrefs="f0032">Figure 32</figref>. All the disruptants showed almost the same or slightly increased yield of ethanol production during glucose fermentation, thus indicating that these disruptants are not inferior in the production level of ethanol to their parent strain even when the carbon source is glucose.</p><heading id="h0036"><u>Example 9: Xylose fermentation test on <i>UTR1, YEF1, FPS1, UTR1 YEF1, UTR1 FPS1</i> and <i>UTR1 YEF1 FPS1</i> disruptants in YPX medium on a 50 ml scale</u></heading><p id="p0084" num="0084">The disruptants bred from HH472 as a parent strain in Example 8 and the parent strain were each cultured in YPD as described in the test methods and then inoculated into YPX medium (50 ml) in a 100 ml medium bottle at 50 mg wet cell/ml. At 30°C, a fermentation test was conducted while stirring with a magnet stirrer (60 rpm). After 2, 8, 22, 29, 46 and 51 hours, aliquots were sampled, centrifuged to separate the yeast cells, and then quantified for xylose, ethanol, xylitol, glycerol and acetic acid by high performance liquid chromatography. The time courses of individual ingredients are shown in <figref idrefs="f0033 f0034 f0035 f0036 f0037">Figures 33 to 37</figref>. All the disruptants showed a reduction in the production levels of xylitol and acetic acid when compared to their parent strain. Glycerol production level was increased in the <i>FPS1</i> disruptants, i.e., the <i>FPS1</i> disruptant, the <i>UTR1 FPS1</i> disruptant and the <i>UTR1 YEF1 FPS1</i> disruptant, whereas ethanol production level was greater in all the disruptants than in their parent strain. Even in the case of fermentation under stirring conditions without aeration, the yield of ethanol from xylose can also be effectively increased when these three genes <i>UTR1</i>, <i>YEF1</i> and <i>FPS1</i> are disrupted either alone or in any combination.</p><heading id="h0037">INDUSTRIAL APPLICABILITY</heading><p id="p0085" num="0085">During ethanol fermentation where pentoses originating from biomass are used as carbon sources, the yield of ethanol production can be increased. In particular, a higher effect can be expected in cases where biomass is rich in hemicelluloses. Moreover, this technique also achieves increased yields in cases where yeast is allowed to produce substances which require NAD for their production, i.e., ethanol production from arabinose, etc.<!-- EPO <DP n="32"> --></p><heading id="h0038"><u>Sequence Listing Free Text</u></heading><p id="p0086" num="0086"><ul><li>SEQ ID NO: 5: synthetic DNA</li><li>SEQ ID NO: 6: synthetic DNA</li><li>SEQ ID NO: 7: synthetic DNA</li><li>SEQ ID NO: 8: synthetic DNA</li><li>SEQ ID NO: 15: synthetic DNA</li><li>SEQ ID NO: 16: synthetic DNA</li><li>SEQ ID NO: 17: synthetic DNA</li><li>SEQ ID NO: 18: synthetic DNA</li><li>SEQ ID NO: 19: synthetic DNA</li><li>SEQ ID NO: 20: synthetic DNA</li><li>SEQ ID NO: 21: synthetic DNA</li><li>SEQ ID NO: 22: synthetic DNA</li><li>SEQ ID NO: 25: synthetic DNA</li><li>SEQ ID NO: 26: synthetic DNA</li><li>SEQ ID NO: 27: synthetic DNA</li><li>SEQ ID NO: 28: synthetic DNA</li></ul></p><heading id="h0039">Sequence Listing</heading><!-- EPO <DP n="33"> --><p id="p0087" num="0087"><img id="ib0006" file="imgb0006.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="34"> --><img id="ib0007" file="imgb0007.tif" wi="137" he="232" img-content="dna" img-format="tif"/><!-- EPO <DP n="35"> --><img id="ib0008" file="imgb0008.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="36"> --><img id="ib0009" file="imgb0009.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="37"> --><img id="ib0010" file="imgb0010.tif" wi="120" he="227" img-content="dna" img-format="tif"/><!-- EPO <DP n="38"> --><img id="ib0011" file="imgb0011.tif" wi="120" he="227" img-content="dna" img-format="tif"/><!-- EPO <DP n="39"> --><img id="ib0012" file="imgb0012.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="40"> --><img id="ib0013" file="imgb0013.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="41"> --><img id="ib0014" file="imgb0014.tif" wi="137" he="232" img-content="dna" img-format="tif"/><!-- EPO <DP n="42"> --><img id="ib0015" file="imgb0015.tif" wi="118" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="43"> --><img id="ib0016" file="imgb0016.tif" wi="116" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="44"> --><img id="ib0017" file="imgb0017.tif" wi="136" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="45"> --><img id="ib0018" file="imgb0018.tif" wi="134" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="46"> --><img id="ib0019" file="imgb0019.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="47"> --><img id="ib0020" file="imgb0020.tif" wi="135" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="48"> --><img id="ib0021" file="imgb0021.tif" wi="121" he="227" img-content="dna" img-format="tif"/><!-- EPO <DP n="49"> --><img id="ib0022" file="imgb0022.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="50"> --><img id="ib0023" file="imgb0023.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="51"> --><img id="ib0024" file="imgb0024.tif" wi="116" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="52"> --><img id="ib0025" file="imgb0025.tif" wi="136" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="53"> --><img id="ib0026" file="imgb0026.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="54"> --><img id="ib0027" file="imgb0027.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="55"> --><img id="ib0028" file="imgb0028.tif" wi="116" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="56"> --><img id="ib0029" file="imgb0029.tif" wi="120" he="227" img-content="dna" img-format="tif"/><!-- EPO <DP n="57"> --><img id="ib0030" file="imgb0030.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="58"> --><img id="ib0031" file="imgb0031.tif" wi="133" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="59"> --><img id="ib0032" file="imgb0032.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="60"> --><img id="ib0033" file="imgb0033.tif" wi="137" he="232" img-content="dna" img-format="tif"/><!-- EPO <DP n="61"> --><img id="ib0034" file="imgb0034.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="62"> --><img id="ib0035" file="imgb0035.tif" wi="132" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="63"> --><img id="ib0036" file="imgb0036.tif" wi="118" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="64"> --><img id="ib0037" file="imgb0037.tif" wi="120" he="227" img-content="dna" img-format="tif"/><!-- EPO <DP n="65"> --><img id="ib0038" file="imgb0038.tif" wi="116" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="66"> --><img id="ib0039" file="imgb0039.tif" wi="131" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="67"> --><img id="ib0040" file="imgb0040.tif" wi="136" he="109" img-content="dna" img-format="tif"/></p></description><claims mxw-id="PCLM56976847" lang="EN" load-source="patent-office"><!-- EPO <DP n="68"> --><claim id="c-en-0001" num="0001"><claim-text>A microorganism deficient in the function of expressing NAD kinase gene.</claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The microorganism according to claim 1, wherein the NAD kinase gene is at least one selected from <i>UTR1</i> gene and <i>YEF1</i> gene.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>The microorganism according to claim 1 or 2, which is further deficient in the function of expressing <i>FPS1</i> gene.</claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>The microorganism according to any one of claims 1 to 3, which is yeast.</claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>The microorganism according to any one of claims 1 to 3, which is <i>Saccharomyces cerevisiae</i>.</claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>The microorganism according to any one of claims 1 to 5, which is transformed with a xylose-metabolizing enzyme gene.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>The microorganism according to claim 6, wherein the xylose-metabolizing enzyme gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</claim-text></claim><claim id="c-en-0008" num="0008"><claim-text>A method for preparing a microorganism whose xylose fermentation ability is increased by causing a deficiency in the function of expressing NAD kinase gene.</claim-text></claim><claim id="c-en-0009" num="0009"><claim-text>The method according to claim 8, wherein the NAD kinase gene is at least one selected from <i>UTR1</i> gene and <i>YEF1</i> gene.</claim-text></claim><claim id="c-en-0010" num="0010"><claim-text>The method according to claim 8 or 9, which further comprises a step of causing a deficiency in the function of expressing <i>FPS1</i> gene.</claim-text></claim><claim id="c-en-0011" num="0011"><claim-text>The method according to any one of claims 8 to 10, wherein the microorganism is yeast.</claim-text></claim><claim id="c-en-0012" num="0012"><claim-text>The method according to any one of claims 8 to 10, wherein the microorganism is <i>Saccharomyces cerevisiae</i>.</claim-text></claim><claim id="c-en-0013" num="0013"><claim-text>The method according to any one of claims 8 to 12, wherein the microorganism is transformed with a xylose-metabolizing enzyme gene.</claim-text></claim><claim id="c-en-0014" num="0014"><claim-text>The method according to claim 13, wherein the xylose-metabolizing enzyme<!-- EPO <DP n="69"> --> gene is at least one selected from the group consisting of xylose reductase gene, xylitol dehydrogenase gene and xylulose kinase gene.</claim-text></claim><claim id="c-en-0015" num="0015"><claim-text>A method for producing ethanol, which comprises a step of contacting the microorganism according to any one of claims 1 to 7 with xylose-containing raw materials.</claim-text></claim><claim id="c-en-0016" num="0016"><claim-text>A microorganism deficient in the function of expressing <i>FPS1</i> gene.</claim-text></claim></claims><drawings mxw-id="PDW16667618" load-source="patent-office"><!-- EPO <DP n="70"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="125" he="207" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="71"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="138" he="140" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="72"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="127" he="139" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="73"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="79" he="133" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="74"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="79" he="140" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="75"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="142" he="138" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="76"> --><figure id="f0007" num="7"><img id="if0007" file="imgf0007.tif" wi="135" he="134" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="77"> --><figure id="f0008" num="8"><img id="if0008" file="imgf0008.tif" wi="154" he="147" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="78"> --><figure id="f0009" num="9"><img id="if0009" file="imgf0009.tif" wi="156" he="147" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="79"> --><figure id="f0010" num="10"><img id="if0010" file="imgf0010.tif" wi="120" he="207" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="80"> --><figure id="f0011" num="11"><img id="if0011" file="imgf0011.tif" wi="117" he="220" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="81"> --><figure id="f0012" num="12"><img id="if0012" file="imgf0012.tif" wi="120" he="209" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="82"> --><figure id="f0013" num="13"><img id="if0013" file="imgf0013.tif" wi="119" he="189" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="83"> --><figure id="f0014" num="14"><img id="if0014" file="imgf0014.tif" wi="114" he="214" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="84"> --><figure id="f0015" num="15"><img id="if0015" file="imgf0015.tif" wi="121" he="215" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="85"> --><figure id="f0016" num="16"><img id="if0016" file="imgf0016.tif" wi="124" he="197" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="86"> --><figure id="f0017" num="17"><img id="if0017" file="imgf0017.tif" wi="123" he="198" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="87"> --><figure id="f0018" num="18"><img id="if0018" file="imgf0018.tif" wi="125" he="195" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="88"> --><figure id="f0019" num="19"><img id="if0019" file="imgf0019.tif" wi="124" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="89"> --><figure id="f0020" num="20"><img id="if0020" file="imgf0020.tif" wi="114" he="216" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="90"> --><figure id="f0021" num="21"><img id="if0021" file="imgf0021.tif" wi="140" he="212" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="91"> --><figure id="f0022" num="22"><img id="if0022" file="imgf0022.tif" wi="138" he="218" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="92"> --><figure id="f0023" num="23"><img id="if0023" file="imgf0023.tif" wi="146" he="218" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="93"> --><figure id="f0024" num="24"><img id="if0024" file="imgf0024.tif" wi="120" he="212" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="94"> --><figure id="f0025" num="25"><img id="if0025" file="imgf0025.tif" wi="108" he="218" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="95"> --><figure id="f0026" num="26"><img id="if0026" file="imgf0026.tif" wi="135" he="147" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="96"> --><figure id="f0027" num="27"><img id="if0027" file="imgf0027.tif" wi="164" he="147" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="97"> --><figure id="f0028" num="28"><img id="if0028" file="imgf0028.tif" wi="134" he="162" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="98"> --><figure id="f0029" num="29"><img id="if0029" file="imgf0029.tif" wi="128" he="207" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="99"> --><figure id="f0030" num="30"><img id="if0030" file="imgf0030.tif" wi="131" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="100"> --><figure id="f0031" num="31"><img id="if0031" file="imgf0031.tif" wi="125" he="213" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="101"> --><figure id="f0032" num="32"><img id="if0032" file="imgf0032.tif" wi="126" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="102"> --><figure id="f0033" num="33"><img id="if0033" file="imgf0033.tif" wi="119" he="221" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="103"> --><figure id="f0034" num="34"><img id="if0034" file="imgf0034.tif" wi="118" he="223" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="104"> --><figure id="f0035" num="35"><img id="if0035" file="imgf0035.tif" wi="115" he="224" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="105"> --><figure id="f0036" num="36"><img id="if0036" file="imgf0036.tif" wi="116" he="226" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="106"> --><figure id="f0037" num="37"><img id="if0037" file="imgf0037.tif" wi="114" he="226" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="165" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="165" he="233" type="tif"/><doc-page id="srep0003" file="srep0003.tif" wi="153" he="233" type="tif"/><doc-page id="srep0004" file="srep0004.tif" wi="158" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
